Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
IWM [NYSE]
iShares Russell 2000
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week1.92%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-1.44%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter1.29%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y-0.90%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year12.11%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range98.84 - 120.51 Perf YTD0.02%
Dividend1.39 P/FCF- EPS past 5Y- ROI- 52W High-4.87% Beta-
Dividend %1.21% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low15.98% ATR1.46
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)46.61 Volatility1.10% 1.22%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.72 Prev Close114.87
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume44.24M Price114.64
Recom- SMA20-1.37% SMA500.11% SMA2001.68% Volume31,707,636 Change-0.20%
24-Jul-14 06:08PM  Yellen's Recent Statements Notwithstanding, Many High-Quality Small-Caps Still Undervalued at Seeking Alpha
02:57PM  Investors Are Getting Nervous About The Quality Of Assets at Seeking Alpha
02:48PM  The Hangover at Seeking Alpha
02:17PM  Jobless Claims Drop To 8-Year Low at Seeking Alpha
02:08PM  Don't Sweat The Small Caps at Seeking Alpha
12:17PM  Midday index, ETF option volumes optionMONSTER
12:02PM  Half Empty or Half Full? at Forbes
10:45AM  A Look Back at the Damage Yahoo Finance Blogs
10:45AM  A Look Back at the Damage Yahoo Finance Blogs
10:25AM  Daily State Of The Markets: The Word Of The Day Is 'Improvement', But... at Seeking Alpha
10:12AM  Bulls Take Notice - Caution Suggested As Credit Markets And Equity Markets Diverge at Seeking Alpha
23-Jul-14 08:04PM  Obvious Yet Hidden - The Long-Awaited S&P 500 Correction Already Happened iSPYETF
03:20PM  What Are U.S. Small Cap Stock Prices Saying About The Economy? at Seeking Alpha
12:24PM  Midday index, ETF option volumes optionMONSTER
11:28AM  10 Signs The Capital Markets Are Confused Yahoo Finance Blogs
10:30AM  Dividend ETFs Buffer Small-Cap Weakness ETF Trends
22-Jul-14 08:43PM  A Change of Narrative Yahoo Finance Blogs
05:31PM  Small Cap Divergence Likely to Hinder Markets Advance Yahoo Finance Blogs
04:52PM  Stocks Rise as Fundamentals Trump Fear at Barrons.com
04:00PM  STOCKS RALLY, HERBALIFE SURGES, S&P TOUCHES ALL-TIME HIGH: Here's What You Need To Know Business Insider
04:00PM  STOCKS RALLY, HERBALIFE SURGES, S&P TOUCHES ALL-TIME HIGH: Here's What You Need To Know Business Insider
03:58PM  Regional Bank Index Not Optimistic Zacks
01:40PM  Janet Sees Little Overvaluation at Seeking Alpha
01:24PM  Broad advance puts market on sound footing at MarketWatch
12:47PM  11 Reasons The Bears Can't Be Too Happy Right Now Benzinga
12:30PM  When Big is Beautiful: Megacaps Break Out at Barrons.com
11:29AM  The Fed Prisoners Dilemma: Sell Now or Keep Dancing? Yahoo Finance Blogs
11:04AM  Never Mind Their Distrust Of Data And Forecasts, Austrians Can Help You Predict The Economy at Seeking Alpha
11:02AM  Small Caps Act Poorly On a Relative Basis Yahoo Finance Blogs
10:05AM  The Question For The Stock Market On The Federal Reserve Side at Seeking Alpha
09:25AM  Daily State Of The Markets: The Bears Can't Be Too Happy Right About Now at Seeking Alpha
08:34AM  Apple, Microsoft poised to wake 'comfortably numb' markets at MarketWatch
07:22AM  Apple, Microsoft poised to wake 'comfortably numb' markets at MarketWatch
06:13AM  Apple, Microsoft poised to wake 'comfortably numb' markets at MarketWatch
05:50AM  Trouble Looming In The Market... at Seeking Alpha
21-Jul-14 06:45PM  Stocks Dip Because the World is a Messy Place; Bubble Talk Resumes at Barrons.com
03:34PM  Chicago Fed: A Modest Deceleration For U.S. Growth In June at Seeking Alpha
03:21PM  Why Isn't The United States Growing Faster? at Seeking Alpha
03:10PM  Do Chart Levels Matter Right Now? Benzinga
01:05PM  You Might Not Realize How Close The Fed Is To Achieving Its Goals Business Insider
01:00PM  What A GDP-Based IMF Would Look Like at Seeking Alpha
11:23AM  STOCKS ARE FALLING DOW DOWN 100 Business Insider
09:55AM  John Hussman: Optimism Vs. Arithmetic at Seeking Alpha
09:17AM  Market Outlook - SPX 20 Day Moving Average Violated at Seeking Alpha
08:40AM  Calvert Chief Investment Officer Natalie Trunow: Risk Premium Up, Increased Volatility Next 6-9 Months at Seeking Alpha
07:01AM  Last weeks action brings a correction that much closer at MarketWatch
20-Jul-14 10:06AM  How to Use Just 4 iShares ETFs to Invest Simply and Effectively at Motley Fool
08:38AM  The First Victims Of The End Of QE - Small Cap Stocks And Junk Bonds at Seeking Alpha
01:37AM  Weighing The Week Ahead: Will Earnings Growth Reignite The Stock Rally? at Seeking Alpha
19-Jul-14 09:05AM  SPY Trends and Influencers July 19, 2014 Yahoo Finance Blogs
03:41AM  [$$] Maintaining Perspective at Barrons.com
18-Jul-14 07:47PM  The Week Ahead: Bond Market Mystery Solved at Forbes
06:27PM  Why you should make money your employee Market Realist
05:21PM  ChartAdvisor for July 17, 2014 at Investopedia
04:53PM  The Purge: Stocks Finish Higher Despite Tough Week at Barrons.com
04:05PM  No Bias Yahoo Finance Blogs
02:49PM  Stocks Are Rallying Into The Weekend Business Insider
02:49PM  Stocks Are Rallying Into The Weekend Business Insider
02:27PM  Must-know: The importance of focusing on financial goals Market Realist
01:54PM  Running not-so-scared: Investors are dumping risk at CNBC
12:14PM  Midday index, ETF option volumes optionMONSTER
10:59AM  When does the 'stealth correction' become the real thing? Yahoo Finance
10:36AM  Today's Market: Big Tech Leads Even With Geopolitical Events Dragging Market Lower at Seeking Alpha
10:12AM  Russell vulnerable to a large decline says Joe Friday! Yahoo Finance Blogs
08:55AM  Daily State Of The Markets: Headline Headache! at Seeking Alpha
08:09AM  Head and Shoulders Everywhere in the Russell 2000! Yahoo Finance Blogs
17-Jul-14 10:35PM  Second Half Economic Outlook: Should I Change My Forecast? Part II at Seeking Alpha
10:31PM  When does the 'stealth correction' become the real thing? Yahoo Finance
05:16PM  Must-know: Where investors can find value Market Realist
02:51PM  The Single Best Predictor Of Equity Returns In 2014? at Seeking Alpha
01:05PM  AAII Sentiment Survey: Individual Investor Optimism Falls To An 8-Week Low at Seeking Alpha
12:15PM  Midday index, ETF option volumes optionMONSTER
11:59AM  Dow Drops 160 Points as Malaysian Plane Crash Jumpstarts Geopolitical Concerns at Barrons.com
09:29AM  The Tolling Bells Of Complacency at Seeking Alpha
08:56AM  Daily State Of The Markets: Indicators Suggest A Pullback Might Be Near, But... at Seeking Alpha
08:30AM  Jobless Claims Beat Expectations Business Insider
08:08AM  Here Comes Jobless Claims... Business Insider
16-Jul-14 06:33PM  The Fed's Valuation Concerns Put These Growth ETFs in Focus Zacks
05:07PM  Dow Industrials Hit Record High, Small Caps Fall as Yellen Speaks Again at Barrons.com
03:32PM  U.S. Producer Prices Rise In June at Seeking Alpha
01:08PM  Which Matters More: Janet Yellen Or Earnings & Economic Data? Benzinga
12:19PM  Back To The Future Part II: The 2007 Parallel Persists at Seeking Alpha
12:16PM  Midday index, ETF option volumes optionMONSTER
11:56AM  Does Yellen Use Technical Analysis? at Forbes
09:20AM  Daily State Of The Markets: Which Matters More: Yellen Or Earnings/Econ Data? at Seeking Alpha
08:50AM  Second Half Economic Outlook: Should I Change My Forecast? at Seeking Alpha
01:50AM  The Federal Reserve Uses Small-Cap, Social Media Stocks To Display Vigilance On Valuations at Seeking Alpha
15-Jul-14 07:55PM  Most Active ETFs Diverge In Recent Sessions at Investor's Business Daily
06:59PM  [$$] Yellen Calls Out Speculative Highfliers at Barrons.com
06:11PM  Yellen Spooks Stocks, Some More Than Others at Barrons.com
01:37PM  John Hussman: Ockham's Razor And The Market Cycle at Seeking Alpha
01:37PM  John Hussman: Occam's Razor And The Market Cycle at Seeking Alpha
12:15PM  Charting a bullish July technical backdrop at MarketWatch
11:47AM  Investors Dispute Yellens Bearish Comments StockTwits
10:15AM  Daily State Of The Markets: Can Earnings Season Carry The Bulls To Higher Ground? at Seeking Alpha
10:01AM  Yellen Says 'Significant' Slack Remains In The Labor Market Business Insider
09:39AM  Do You Trust The Fed? at Seeking Alpha
09:00AM  Inverse Small-Cap ETFs to Capitalize on Short-Term Weakness ETF Trends
14-Jul-14 04:16PM  Parallels Between 1987 and Today Should You Be Spooked? ETFguide
12:26PM  Daily State Of The Markets: Hopes For ECB Action Improves The Mood at Seeking Alpha
The investment seeks to track the investment results of an index composed of small-capitalization U.S. equities. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It seeks to track the investment results of the Russell 2000 Index (the "underlying index"), which measures the performance of the small-capitalization sector of the U.S. equity market.
DHR [NYSE]
Danaher Corp.
IndexS&P 500 P/E20.53 EPS (ttm)3.70 Insider Own0.20% Shs Outstand700.68M Perf Week2.57%
Market Cap53.23B Forward P/E18.25 EPS next Y4.16 Insider Trans1.37% Shs Float608.03M Perf Month-4.02%
Income2.64B PEG1.56 EPS next Q0.91 Inst Own78.80% Short Float1.16% Perf Quarter3.26%
Sales19.56B P/S2.72 EPS this Y17.30% Inst Trans0.37% Short Ratio2.36 Perf Half Y-1.22%
Book/sh33.83 P/B2.25 EPS next Y12.36% ROA7.60% Target Price86.03 Perf Year12.70%
Cash/sh4.74 P/C16.03 EPS next 5Y13.13% ROE11.70% 52W Range64.56 - 81.04 Perf YTD-1.34%
Dividend0.40 P/FCF18.66 EPS past 5Y13.90% ROI9.30% 52W High-6.26% Beta1.15
Dividend %0.53% Quick Ratio1.70 Sales past 5Y8.50% Gross Margin52.20% 52W Low17.67% ATR1.04
Employees66000 Current Ratio2.20 Sales Q/Q4.80% Oper. Margin17.30% RSI (14)40.14 Volatility1.29% 1.13%
OptionableYes Debt/Eq0.13 EPS Q/Q9.20% Profit Margin13.50% Rel Volume1.08 Prev Close75.61
ShortableYes LT Debt/Eq0.13 EarningsJul 17 BMO Payout4.60% Avg Volume2.97M Price75.97
Recom1.70 SMA20-2.41% SMA50-2.88% SMA2000.95% Volume3,218,024 Change0.48%
09-Apr-14Upgrade ISI Group Buy → Strong Buy $86
31-Dec-13Reiterated FBR Capital Mkt Perform $73 → $83
10-Jul-13Reiterated ISI Group Buy $69.50 → $73
18-Apr-13Reiterated ISI Group Buy $70 → $68
25-Mar-13Reiterated Deutsche Bank Hold $64 → $70
18-Mar-13Reiterated FBR Capital Mkt Perform $54 → $63
30-Jan-13Reiterated UBS Buy $60 → $69
30-Jan-13Reiterated Barclays Equal Weight $23 → $27
29-Jan-13Reiterated ISI Group Buy $64 → $70
14-Jan-13Reiterated Barclays Overweight $57 → $60
07-Jan-13Upgrade ISI Group Neutral → Buy $61 → $64
07-Jan-13Reiterated Deutsche Bank Hold $62 → $64
13-Dec-12Reiterated ISI Group Hold $58.50 → $61
07-Dec-12Initiated BMO Capital Markets Outperform
12-Oct-12Initiated Deutsche Bank Hold $62
01-Feb-12Reiterated Barclays Capital Overweight $54 → $58
13-Jan-12Reiterated Longbow Buy $52 → $60
13-Oct-11Reiterated Longbow Buy $60 → $52
07-Jul-11Reiterated Oppenheimer Outperform $58 → $62
25-Apr-11Reiterated Longbow Buy $55 → $60
23-Jul-14 01:04PM  DANAHER CORP /DE/ Financials EDGAR Online Financials
01:02PM  Danaher Corp. Sells Off, but Is It a Good Value? at Motley Fool
18-Jul-14 05:48PM  Heavy Static At Danaher Corporation at Motley Fool
06:55AM  Danaher (DHR) Falls: Stock Goes Down 5.6% Zacks
17-Jul-14 07:42PM  Why SanDisk Corp., Mattel Inc., and Danaher Corp. Are Todays 3 Worst Stocks at Motley Fool -5.64%
06:49PM  Danaher earnings disappoint Investor's Business Daily
02:08PM  Danaher's (DHR) CEO Larry Culp on Q2 2014 Results - Earnings Call Transcript Seeking Alpha
11:36AM  Danaher Q2 Earnings, Guidance Disappoint Wall Street at Investor's Business Daily
10:44AM  Why Danaher (DHR) Stock Is Down Today at TheStreet
10:20AM  Danaher Misses Q2 Earnings Estimates, Up Y/Y, Outlook Cut Zacks
10:06AM  Danaher (DHR) Is Today's Roof Leaker Stock at TheStreet
08:00AM  Danaher Corp Earnings Call scheduled for 8:00 am ET today CCBN
07:07AM  Q2 2014 Danaher Earnings Release - Before Market Open CCBN
06:00AM  DANAHER CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit EDGAR Online
06:00AM  DANAHER CORP /DE/ Files SEC form 10-Q, Quarterly Report EDGAR Online
06:00AM  Danaher Reports Record Second Quarter 2014 Results PR Newswire
16-Jul-14 04:00PM  Beckman Coulter to Acquire Siemens Healthcare Diagnostics' Clinical Microbiology Business PR Newswire
03:27PM  Notable companies reporting before tomorrow's open at theflyonthewall.com
14-Jul-14 08:40AM  Can Danaher (DHR) Keep the Earnings Streak Alive? Zacks
13-Jul-14 06:21PM  Will earnings tell the story markets need to hear? at CNBC
11-Jul-14 05:53PM  Will earnings tell the story markets need to hear? at CNBC
10-Jul-14 04:12PM  Spinversions: How a Mega Co. Can Join In on Tax-Cutting Deals Bloomberg
26-Jun-14 04:31PM  Danaher Schedules Second Quarter 2014 Earnings Conference Call Thomson Reuters ONE
04:31PM  Danaher Schedules Second Quarter 2014 Earnings Conference Call
24-Jun-14 02:12PM  Will Danaher Corporation Bounce Back With a Big Buyout? at Motley Fool
02:12PM  Will Danaher Corporation Bounce Back With a Big Buyout?
19-Jun-14 10:06AM  Danahers $12 Billion Deal Engine Is Idling: Real M&A at Bloomberg
10:06AM  Danahers $12 Billion Deal Engine Is Idling: Real M&A
08:02AM  Danaher to Webcast Investor and Analyst Meeting Thomson Reuters ONE
08:02AM  Danaher to Webcast Investor and Analyst Meeting
07:48AM  PerkinElmer, Agilent unit seen as potential Danaher targets, Bloomberg says theflyonthewall.com
07:48AM  PerkinElmer, Agilent unit seen as potential Danaher targets, Bloomberg says
18-Jun-14 12:37AM  This may be bad news for the housing market Talking Numbers
12:37AM  Are cracks forming in the housing market? Talking Numbers
16-Jun-14 06:21PM  Cramer: Perfectly legal strategy for avoiding taxes at CNBC
06:15PM  [video] Cramer rides the tax inversion wave at CNBC
06:15PM  [video] Cramer rides the tax inversion wave
14-Jun-14 08:14PM  A Rare Sale on Danaher Shares at The Wall Street Journal
08:14PM  A Rare Sale on Danaher Shares
10-Jun-14 05:00PM  Why did Halvorsens Viking Global boost its position in Illumina? Market Realist
09:00AM  Andreas Halvorsens Viking Global sells its shares in Danaher Market Realist
09:00AM  Andreas Halvorsens Viking Global sells its shares in Danaher
08-Jun-14 02:33PM  Barron's Recap: The New Face Of Wall Street Benzinga
02:33PM  Barron's Recap: The New Face Of Wall Street
07-Jun-14 12:01AM  [$$] Danaher's Best Deal Could Be Its Shares at Barrons.com
12:01AM  [$$] Danaher's Best Deal Could Be Its Shares
06-Jun-14 03:43PM  Andreas Halvorsen and Viking Global Investors 1Q 2014 positions Market Realist
04-Jun-14 10:00AM  James Cunningham Joins Doble Engineering Company as Vice President of Sales & Marketing PR Newswire
10:00AM  James Cunningham Joins Doble Engineering Company as Vice President of Sales & Marketing
08:31AM  Danaher to Present at Goldman Sachs Global Healthcare Conference Thomson Reuters ONE
08:31AM  Danaher to Present at Goldman Sachs Global Healthcare Conference
03-Jun-14 08:44AM  NetScout's Performance Management Managing Good Performance at Seeking Alpha
29-May-14 08:11AM  Stock-Specific Opportunities in Underlying Demand in the Electrical Equipment Sector: A Wall Street Transcript Interview with Ajay Kejriwal, a Senior Analyst and Senior Vice President of FBR Capital Markets & Co., Covering the Multi-Industr Wall Street Transcript
27-May-14 12:09PM  Luis Manuel Ramirez, the President and CEO of Global Power Equipment Group Inc. (GLPW), Interviews with The Wall Street Transcript Wall Street Transcript
23-May-14 07:58PM  Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan at TheStreet
07:33PM  Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan at TheStreet
06:27PM  Cramer's next potential break-up play... say what? at CNBC
06:25PM  [video] Potential break up play: Danaher (DHR) at CNBC
07:16AM  Danaher, Tyco draw bullish plays optionMONSTER
06:07AM  Stocks with implied volatility movement; DHR BWP at theflyonthewall.com
22-May-14 01:21PM  Your first trade for Friday at CNBC
12:58PM  [video] FMHR Final Trade: Long Priceline.com & more at CNBC
11:14AM  Jim Cramer's Stop Trading: Get Ahead of Danaher Earnings Now at TheStreet
10:45AM  The Big Value Theme for Danaher: Is a Breakup in the Works? at 24/7 Wall St.
10:45AM  The Big Value Theme for Danaher: Is a Breakup in the Works? 24/7 Wall St.
09:10AM  Citigroup Adds Danaher (DHR) To US Focus List at TheStreet
06:10AM  Danaher added to US Focus List at Citigroup at theflyonthewall.com
21-May-14 09:39AM  Danaher has a conference call hosted by JPMorgan at theflyonthewall.com
07:55AM  Danaher risk/reward 'unusually positive,' says JPMorgan at theflyonthewall.com
15-May-14 10:11AM  3M and Danaher: A Tale of Two Industrials at Barrons.com
14-May-14 08:02AM  Danaher to Present at Electrical Products Group Conference Thomson Reuters ONE
13-May-14 06:17PM  Danaher recommends holders reject TRC Capital's 'mini-tender offer' at theflyonthewall.com
06:16PM  Danaher Recommends Shareholders Reject TRC Capital Corporation's Below-Market Price "Mini-Tender Offer"; SEC Has Issued Investor Alert Regarding "Mini-Tender Offers" Thomson Reuters ONE
12-May-14 06:45AM  Huge leveraged trade in Danaher optionMONSTER
08-May-14 05:18PM  DANAHER CORP /DE/ Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
06-May-14 04:01PM  Danaher Announces Quarterly Dividend Thomson Reuters ONE
07:00AM  Must-See Charts: Fight the Selling With These 5 Trades at TheStreet
02-May-14 02:36PM  Is Becton, Dickinson and Company a Buy? at Motley Fool
29-Apr-14 12:10PM  How Does Honeywell International Stack Up Against Its Peers? at Motley Fool
28-Apr-14 12:18PM  Roper Beats on Q1 Earnings, Revs Zacks
25-Apr-14 01:24PM  Is Danaher a Good Value? at Motley Fool
22-Apr-14 01:04PM  DANAHER CORP /DE/ Financials EDGAR Online Financials
21-Apr-14 04:33PM  5 Companies Boosting Their Dividend By at Least 200% in the 1st Quarter at Motley Fool
01:02PM  3 Stocks Driving The Industrial Goods Sector Higher at TheStreet
12:24PM  December 20th Options Now Available For Danaher (DHR) at TheStreet
11:42AM  This Law School Professor Believes Robots May Lead To An Increase In Prostitution Business Insider
17-Apr-14 06:32PM  Even With A Change At The Top, Danaher Corporation Will Roll On at Motley Fool
02:36PM  Danaher's CEO Discusses Q1 2014 Results - Earnings Call Transcript Seeking Alpha
12:31PM  Danaher CEO Change, Guidance Underwhelm Investors at Investor's Business Daily
09:20AM  Danaher Beats on Q1 Earnings Zacks
07:30AM  Danaher Earnings Call scheduled for 7:30 am ET today CCBN
07:07AM  Q1 2014 Danaher Earnings Release - Before Market Open CCBN
16-Apr-14 05:25PM  [$$] Danaher Unveils CEO Transition Plan at The Wall Street Journal
05:23PM  [$$] Danaher Unveils CEO Transition Plan at The Wall Street Journal
04:09PM  DANAHER CORP /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
04:02PM  DANAHER CORP /DE/ Files SEC form 10-Q, Quarterly Report EDGAR Online
04:01PM  Danaher Reports Record First Quarter 2014 Results PR Newswire
04:01PM  Danaher Corporation Announces CEO Transition PR Newswire
03:05PM  Robert B. Reynolds Jr., the Chairman and VP of Operations of First Liberty Power Corporation (FLPC), Interviews with The Wall Street Transcript Wall Street Transcript
14-Apr-14 03:27PM  Danaher Corporation (DHR) Marked As Today's Roof Leaker Stock at TheStreet
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Test & Measurement segment provides test, measurement, and monitoring products that are used in electronic design, manufacturing, and technology development; network monitoring, management, and optimization tools; and security solutions for communications and enterprise networks. Its Environmental segment offers instrumentation and disinfection systems to analyze and manage the quality of water; and solutions and services focused on fuel dispensing, remote fuel management, point-of-sale systems, payment systems, environmental compliance, vehicle tracking, and fleet management. The company's Life Sciences & Diagnostics segment provides various research and clinical tools for scientists to study cells and its components; and a range of analytical instruments, reagents, consumables, software, and services for hospitals, physician's offices, reference laboratories, and various critical care settings. Its Dental segment provides dental consumables, equipment, and services for the diagnosis, treatment, and prevention of disease and ailments of the teeth, gums, and supporting bone. Danaher Corporation's Industrial Technologies segment offers equipment, consumables, and software for consumer and industrial products; and electromechanical motion control solutions for the industrial automation and packaging markets. This segment also provides sensors and controls products instruments to manufacturing markets and electric utility industry; energetic material systems to systems integrators and prime contractors; and supplemental braking systems for commercial vehicles. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, District of Columbia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SCHWIETERS JOHN TDirectorMay 28Option Exercise26.188,000209,44019,752May 30 07:29 AM
SCHWIETERS JOHN TDirectorMay 28Sale78.738,000629,84011,752May 30 07:29 AM
Graham Jonathan PSenior VP & GCMay 12Sale75.009,973747,94531,569May 14 05:51 PM
COMAS DANIEL LEVP & CFOMay 02Sale73.3639,9422,930,06588,935May 06 05:54 PM
Joyce Thomas Patrick JREVP and CEO-DesignateMay 02Sale73.4223,1911,702,61479,954May 06 05:53 PM
Raskas DanielSVP-Corporate DevelopmentMay 01Sale73.4811,158819,90119,048May 05 05:40 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerFeb 25Sale76.856,250480,31318,367Feb 26 08:19 AM
COMAS DANIEL LEVP & CFOOct 24Sale71.6550,0003,582,650150,907Oct 28 05:26 PM
Raskas DanielSVP-Corporate DevelopmentOct 18Option Exercise28.5020,000570,00055,290Oct 21 06:00 PM
Raskas DanielSVP-Corporate DevelopmentOct 18Sale71.9920,0001,439,76035,290Oct 21 06:00 PM
LICO JAMES AExecutive Vice PresidentOct 01Option Exercise22.6250,0001,131,000171,931Oct 02 05:32 PM
LICO JAMES AExecutive Vice PresidentOct 01Sale69.3850,0003,468,900121,931Oct 02 05:32 PM
EHRLICH DONALD JDirectorAug 29Option Exercise26.188,000209,44095,700Sep 03 06:23 PM
EHRLICH DONALD JDirectorAug 29Sale65.258,000522,00087,700Sep 03 06:23 PM
Joyce Thomas Patrick JREVPAug 06Option Exercise30.7348,0001,475,040172,211Aug 07 08:34 AM
Joyce Thomas Patrick JREVPAug 06Sale67.0448,0003,218,064124,211Aug 07 08:34 AM
WY [NYSE]
Weyerhaeuser Co.
IndexS&P 500 P/E32.05 EPS (ttm)1.00 Insider Own0.20% Shs Outstand526.19M Perf Week-0.62%
Market Cap16.86B Forward P/E19.05 EPS next Y1.68 Insider Trans23.03% Shs Float517.17M Perf Month-0.37%
Income579.00M PEG6.41 EPS next Q0.35 Inst Own93.60% Short Float18.44% Perf Quarter12.34%
Sales8.56B P/S1.97 EPS this Y33.80% Inst Trans0.12% Short Ratio11.30 Perf Half Y6.44%
Book/sh11.69 P/B2.74 EPS next Y24.04% ROA4.00% Target Price34.40 Perf Year14.42%
Cash/sh1.48 P/C21.62 EPS next 5Y5.00% ROE9.10% 52W Range25.86 - 33.75 Perf YTD3.02%
Dividend0.88 P/FCF45.58 EPS past 5Y17.90% ROI7.20% 52W High-5.04% Beta1.49
Dividend %2.75% Quick Ratio1.60 Sales past 5Y1.00% Gross Margin21.40% 52W Low23.94% ATR0.45
Employees13700 Current Ratio2.20 Sales Q/Q1.70% Oper. Margin14.20% RSI (14)47.71 Volatility0.98% 1.50%
OptionableYes Debt/Eq0.79 EPS Q/Q19.20% Profit Margin6.80% Rel Volume0.37 Prev Close32.12
ShortableYes LT Debt/Eq0.79 EarningsAug 01 BMO Payout86.00% Avg Volume8.44M Price32.05
Recom2.20 SMA20-1.73% SMA501.47% SMA2006.76% Volume3,085,761 Change-0.22%
29-Apr-13Reiterated UBS Sell $20 → $24
29-Jan-13Reiterated Argus Buy $33 → $36
28-Jan-13Downgrade RBC Capital Mkts Outperform → Sector Perform $30 → $31
16-Jan-13Reiterated BMO Capital Markets Market Perform $28.50 → $33
17-Jul-12Downgrade BMO Capital Markets Market Perform → Underperform
06-Jul-12Downgrade DA Davidson Buy → Neutral $27 → $23
05-Mar-12Upgrade BMO Capital Markets Underperform → Market Perform $33 → $36
06-Feb-12Reiterated BMO Capital Markets Underperform $16 → $20
31-Oct-11Upgrade Deutsche Bank Sell → Hold $19 → $19
12-Aug-11Upgrade RBC Capital Mkts Underperform → Sector Perform $18 → $18
10-Aug-11Upgrade UBS Sell → Neutral
05-Aug-11Upgrade DA Davidson Neutral → Buy $22 → $22
01-Aug-11Reiterated Barclays Capital Overweight $33 → $31
06-Jun-11Upgrade DA Davidson Underperform → Neutral
07-Feb-11Reiterated Deutsche Bank Hold $20 → $24
07-Feb-11Downgrade UBS Neutral → Sell $18 → $18
07-Feb-11Downgrade RBC Capital Mkts Sector Perform → Underperform $18 → $18
07-Feb-11Downgrade McAdams Wright Ragen Buy → Hold $22
06-Jan-11Downgrade DA Davidson Buy → Neutral $20.50 → $22
10-Dec-10Initiated Stifel Nicolaus Hold
24-Jul-14 02:07PM  Weyerhaeuser and DuPont Pioneer Enter Technology License Agreement PR Newswire
21-Jul-14 04:43PM  [video] Barse likes Weyerhaeuser & BNY Mellon at CNBC
11-Jul-14 08:15AM  Weyerhaeuser Joins the 5 Most Shorted NYSE Stocks at 24/7 Wall St.
10-Jul-14 06:28PM  Is Bigger Better For Builder TRI Pointe? Investor's Business Daily
02:54PM  Weyerhaeuser Will Likely Increase Its Dividend In 2014 at Seeking Alpha
11:29AM  TRI Pointe Appears Compelling After Absorbing Weyerhaeuser's Homebuilder at Seeking Alpha
09-Jul-14 04:47PM  WEYERHAEUSER CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04:30PM  Weyerhaeuser Announces Final Proration Factor of 28.55 Percent for Shares Tendered in Exchange Offer PR Newswire
03:26PM  Break Up Bonanza at Forbes
08-Jul-14 12:47PM  Why TRI Pointe Homes (TPH) Stock Is Climbing Today at TheStreet
11:40AM  Weyerhaeuser Closes WRECO Spilt-Off to Tri Ponte Zacks
08:00AM  TRI Pointe Homes Closes $2.8 Billion Merger with Weyerhaeuser Real Estate Company Business Wire
07-Jul-14 05:59PM  With Merger Closed, TRI Pointe Homes to Focus on Expansion, New Services at The Wall Street Journal
05:16PM  With Merger Closed, TRI Pointe Homes to Focus on Expansion, New Services at The Wall Street Journal
01:35PM  WEYERHAEUSER CO Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Change in Directors or Princi EDGAR Online
01:03PM  3 Stocks Pushing The Real Estate Industry Downward at TheStreet
12:17PM  Weyerhaeuser Closes Transaction to Separate its Homebuilding Business PR Newswire
03-Jul-14 05:16PM  NYSE stocks posting largest volume increases AP
02:46PM  How Caterpillar, Weyerhaeuser, and Tata Motors Set New Highs Today at Motley Fool
01:04PM  WEYERHAEUSER CO Financials EDGAR Online Financials
11:59AM  Unusual Social Activity Today Around Weyerhaeuser (WY) at TheStreet
10:46AM  Why Weyerhauser (WY) Stock Hit a One-Year High Today at TheStreet
08:55AM  WEYERHAEUSER CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:48AM  Weyerhaeuser Announces Preliminary Results Of Exchange Offer PR Newswire
12:00AM  Climate-Driven Wildfires Consume Forest Service Budget Bloomberg
02-Jul-14 01:04PM  WEYERHAEUSER CO Financials EDGAR Online Financials
01-Jul-14 12:30PM  Weyerhaeuser Announces Final Exchange Ratio for WRECO Split-Off Zacks
30-Jun-14 06:07PM  S&P Dow Jones Indices Announces Treatment of Weyerhaeuser Co. Split-off in S&P 500; TRI Pointe Homes Not Added to an S&P Index PR Newswire
05:13PM  WEYERHAEUSER CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04:27PM  Weyerhaeuser Sets Final Exchange Ratio for Split-off of WRECO and Announces Automatic Extension of Exchange Offer to Midnight on Wednesday, July 2, 2014 PR Newswire
01:04PM  3 Stocks Advancing The Industrial Goods Sector at TheStreet
11:14AM  Why International Paper (IP) Stock Is Higher Today at TheStreet
26-Jun-14 01:04PM  Weyerhaeuser to release second quarter results on August 1 PR Newswire
01:04PM  Weyerhaeuser to release second quarter results on August 1
25-Jun-14 10:40AM  Weyerhaeuser Touches New 52-Week High Zacks
10:40AM  Weyerhaeuser Touches New 52-Week High
24-Jun-14 04:53PM  Why TheStreet Ratings Team Rates Weyerhauser (WY) Stock a "Buy" at TheStreet
04:53PM  Why TheStreet Ratings Team Rates Weyerhauser (WY) Stock a "Buy"
12:54PM  Trade-Ideas: Weyerhaeuser (WY) Is Today's "Barbarian At The Gate" Stock at TheStreet
12:54PM  Trade-Ideas: Weyerhaeuser (WY) Is Today's "Barbarian At The Gate" Stock
19-Jun-14 07:36PM  Weyerhaeuser Receives Jefferson Award for Outstanding Service by a Major Corporation PR Newswire
07:36PM  Weyerhaeuser Receives Jefferson Award for Outstanding Service by a Major Corporation
17-Jun-14 02:00PM  Rayonier's CEO Is Jumping Ship To Its Spin-Off - Should You? at Seeking Alpha
13-Jun-14 04:43PM  Weyerhaeuser Shares Sustainability Performance Online PR Newswire
04:43PM  Weyerhaeuser Shares Sustainability Performance Online
08:39AM  Weyerhaeuser's Exchange Offer (WRECO/TRI Pointe): Reasons Not To Tender at Seeking Alpha
08:39AM  Weyerhaeuser's Exchange Offer (WRECO/TRI Pointe): Reasons Not To Tender
12-Jun-14 02:54PM  Weyerhaeuser Company -- Moody's changes Weyerhaeuser's Baa3 rating outlook to positive Moody's
02:54PM  Weyerhaeuser Company -- Moody's changes Weyerhaeuser's Baa3 rating outlook to positive at Moody's
02:54PM  Weyerhaeuser Company -- Moody's changes Weyerhaeuser's Baa3 rating outlook to positive
09-Jun-14 05:58PM  Dzida Named President of Weyerhaeuser Canadian Subsidiary PR Newswire
05:58PM  Dzida Named President of Weyerhaeuser Canadian Subsidiary
06-Jun-14 08:26AM  Oil States Just Unlocked Huge Shareholder Value at Motley Fool
08:26AM  Oil States Just Unlocked Huge Shareholder Value
03-Jun-14 01:03PM  AGNC, NLY And WY, Pushing Real Estate Industry Downward at TheStreet
28-May-14 06:58PM  Should Weyerhaeuser Shareholders Tender For The WRECO/TRI Pointe Spin-Off? at Seeking Alpha
06:58PM  Should Weyerhaeuser Shareholders Tender For The WRECO/TRI Pointe Spin-Off?
25-May-14 07:06AM  Timberrrr! Where Lumber Prices Are Going at Seeking Alpha
07:06AM  Timberrrr! Where Lumber Prices Are Going
23-May-14 04:10PM  Weyerhaeuser Spilts Off WRECO Zacks
04:10PM  Weyerhaeuser Spilts Off WRECO
11:54AM  Why Weyerhaeuser (WY) Stock Is Higher at TheStreet
11:54AM  Why Weyerhaeuser (WY) Stock Is Higher
22-May-14 05:26PM  WEYERHAEUSER CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04:56PM  Weyerhaeuser commences split-off exchange offer for WRECO in connection with transaction with TRI Pointe PR Newswire
10:23AM  High option volume stocks at theflyonthewall.com
13-May-14 03:21PM  Weyerhaeuser Company -- Moody's says Weyerhaeuser divesting WRECO via split-off is credit positive at Moody's
03:10PM  Weyerhaeuser Spins Off Real Estate Unit Zacks
12-May-14 06:19PM  Weyerhaeuser to spin off real estate business AP
04:33PM  Weyerhaeuser announces intention to split of WRECO at theflyonthewall.com
04:32PM  Weyerhaeuser announce intention to split of WRECO at theflyonthewall.com
04:20PM  Weyerhaeuser Announces Intention to Split-Off Weyerhaeuser Real Estate Company PR Newswire
08-May-14 10:48AM  High option volume stocks: WY ODP AES FOX TWGP RGEN at theflyonthewall.com
10:42AM  High option volume stocks: POWR BKD HMY CTL WY at theflyonthewall.com
07-May-14 01:04PM  WEYERHAEUSER CO Financials EDGAR Online Financials
06-May-14 06:30PM  Stock Building Supply Growing Faster Than End Markets at Investor's Business Daily
30-Apr-14 05:28PM  WEYERHAEUSER CO Files SEC form 10-Q, Quarterly Report EDGAR Online
07:52AM  A Look At Plum Creek Timber Following First Quarter Earnings at Seeking Alpha
28-Apr-14 05:13PM  Weyerhaeuser announces changes to its Timberlands leadership team PR Newswire
25-Apr-14 06:54PM  Weyerhaeuser's CEO Discusses Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
10:40AM  Weyerhaeuser's Q1 Earnings Beats Est. Zacks
10:32AM  Despite Difficult Weather Weyerhaeuser Company Tops Expectations at Motley Fool
07:07AM  Q1 2014 Weyerhaeuser Co. Earnings Release - Before Market Open CCBN
06:53AM  [$$] Weyerhaeuser Profit Rises at The Wall Street Journal
06:41AM  Longview Timber deal boosts Weyerhaeuser profit Reuters
06:01AM  WEYERHAEUSER CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
03:40AM  [$$] Weyerhaeuser Profit Rises at The Wall Street Journal
03:32AM  Weyerhaeuser Q1 profit rises 27 pct Reuters
03:05AM  Weyerhaeuser Reports First Quarter Results PR Newswire
24-Apr-14 01:36PM  Weyerhaeuser Company Earnings: Will Housing Hurt Growth? at Motley Fool
15-Apr-14 01:03PM  3 Stocks Dragging The Real Estate Industry Downward at TheStreet
14-Apr-14 07:55PM  Weyerhaeuser announces leadership changes PR Newswire
06:45AM  Bears take aim at Weyerhaeuser optionMONSTER
11-Apr-14 03:29PM  Adam D. Zambanini, VP of Marketing of Trex Company, Inc. (TREX), Interviews with The Wall Street Transcript Wall Street Transcript
10-Apr-14 04:16PM  Weyerhaeuser Company Declares Dividend PR Newswire
02-Apr-14 05:35AM  The Coming Bull Market In Timber at Seeking Alpha
01-Apr-14 04:20PM  Finding Portfolio Serenity In the Forest at Investopedia
31-Mar-14 10:02AM  A Wall Street Transcript Interview with Susan L. Dambekaln, Founder and Portfolio Manager of Capital Innovations, LLC, a Leading Real Assets Manager: Basic Needs Investing in Global Agribusiness, Timber and Infrastructure Wall Street Transcript
25-Mar-14 02:47PM  Weyerhaeuser to release first quarter results on April 25 PR Newswire
19-Mar-14 06:04PM  B.C. Plans Back-to-Work Law for Vancouver Port Truckers Strike at Bloomberg
Weyerhaeuser Company, a forest products company, grows and harvests trees, builds homes, and manufactures forest products worldwide. It grows and harvests trees for use as lumber, other wood and building products, and pulp and paper. The company manages 6.4 million acres of private commercial forestland; and has long-term licenses on 13.9 million acres of forestland. It also offers timber; minerals, such as rock, sand, and gravel, as well as oil and gas to construction and energy markets; logs; timberland tracts; and seed and seedlings, poles, plywood, and hardwood lumber products. In addition, the company provides structural lumber products for structural framing; engineered lumber products for floor and roof joists, and headers and beams; structural panels for structural sheathing, subflooring, and stair treading for wood products dealers, do-it-yourself retailers, builders, and industrial users. Further, it offers building products comprising cedar, decking, siding, insulation, rebar, and engineered lumber connectors. Additionally, the company offers fluff pulp for use in sanitary disposable products; papergrade pulp for printing and writing papers, and tissues; specialty chemical cellulose pulp for use in textiles, absorbent products, specialty packaging, and high-bulking fibers; liquid packaging board converted into containers; and slush and wet lap pulp for manufacturing paper products. It also constructs single-family houses, as well as develops residential lots and land for construction and sale; and master-planned communities with mixed-use property. The company sells its cellulose fibers products through direct sales network, and liquid packaging products directly to carton and food product packaging converters; and wood products through sales organizations and distribution facilities. Weyerhaeuser Company has been elected to be taxed as a real estate investment trust. The company was founded in 1900 and is headquartered in Federal Way, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Orser Peter MSubsidiary Pres.Jun 05Option Exercise20.0066,4141,328,190133,991Jun 06 06:50 PM
Orser Peter MSubsidiary Pres.Jun 05Sale31.3052,0001,627,59581,991Jun 06 06:50 PM
MCDADE SANDY DSenior Vice PresidentMar 07Option Exercise14.8015,427228,366105,353Mar 10 05:13 PM
MCDADE SANDY DSenior Vice PresidentMar 07Sale29.9215,427461,51089,926Mar 10 05:13 PM
Hunter Rhonda DSr. Vice PresidentFeb 11Option Exercise23.6685520,22918,032Feb 12 12:59 PM
Hunter Rhonda DSr. Vice PresidentFeb 11Sale30.1485525,77116,611Feb 12 12:59 PM
Chandrasekaran SrinivasanSenior Vice PresidentJan 13Option Exercise23.674,446105,21995,224Jan 14 08:40 PM
Chandrasekaran SrinivasanSenior Vice PresidentJan 13Sale30.504,446135,60490,778Jan 14 08:40 PM
Blocker Adrian MSenior Vice PresidentDec 17Buy29.991,66349,8736,693Dec 18 03:53 PM
Blocker Adrian MSenior Vice PresidentDec 13Buy29.931,66849,9235,030Dec 17 12:46 PM
Blocker Adrian MSenior Vice PresidentDec 12Buy29.771,67749,9243,362Dec 12 07:10 PM
Blocker Adrian MSenior Vice PresidentDec 11Buy29.631,68549,9241,685Dec 12 06:53 PM
MCDADE SANDY DSenior Vice PresidentNov 27Option Exercise19.1232,864628,346112,781Nov 27 06:53 PM
Hooper John ASenior Vice PresidentNov 27Option Exercise23.672,92069,10558,307Nov 27 07:15 PM
Hooper John ASenior Vice PresidentNov 27Sale30.662,92089,53555,387Nov 27 07:15 PM
MCDADE SANDY DSenior Vice PresidentNov 27Sale30.4932,8641,001,85979,917Nov 27 06:53 PM
GIDEON THOMAS FExecutive Vice PresidentNov 26Option Exercise11.4478,631899,349229,570Nov 27 05:36 PM
GIDEON THOMAS FExecutive Vice PresidentNov 26Sale27.7578,6312,182,081150,939Nov 27 05:36 PM
MCDADE SANDY DSenior Vice PresidentNov 07Option Exercise11.7935,997424,357115,914Nov 08 05:48 PM
MCDADE SANDY DSenior Vice PresidentNov 07Sale29.0935,9971,046,99479,917Nov 08 05:48 PM
GIDEON THOMAS FExecutive Vice PresidentNov 06Option Exercise14.58141,5182,062,991292,457Nov 08 02:55 PM
GIDEON THOMAS FExecutive Vice PresidentNov 06Sale29.36141,5184,155,181150,939Nov 08 02:55 PM
Bedient Patricia MExecutive Vice President & CFONov 04Option Exercise23.6726,544628,190166,426Nov 06 01:52 PM
Bedient Patricia MExecutive Vice President & CFONov 04Sale30.4726,544808,905139,882Nov 06 01:52 PM
CELG [NASD]
Celgene Corporation
IndexS&P 500 P/E54.90 EPS (ttm)1.57 Insider Own0.20% Shs Outstand798.00M Perf Week3.68%
Market Cap68.78B Forward P/E17.83 EPS next Y4.84 Insider Trans20.45% Shs Float793.09M Perf Month0.56%
Income1.34B PEG2.18 EPS next Q0.89 Inst Own82.00% Short Float1.89% Perf Quarter22.05%
Sales6.76B P/S10.18 EPS this Y1.80% Inst Trans-0.04% Short Ratio2.94 Perf Half Y2.27%
Book/sh5.53 P/B15.59 EPS next Y31.82% ROA10.40% Target Price95.18 Perf Year26.75%
Cash/sh6.40 P/C13.46 EPS next 5Y25.17% ROE25.20% 52W Range65.76 - 90.50 Perf YTD2.01%
Dividend- P/FCF30.21 EPS past 5Y24.30% ROI15.40% 52W High-4.76% Beta1.08
Dividend %- Quick Ratio2.70 Sales past 5Y23.60% Gross Margin94.90% 52W Low31.06% ATR2.36
Employees5100 Current Ratio2.90 Sales Q/Q18.10% Oper. Margin27.40% RSI (14)51.99 Volatility2.27% 2.50%
OptionableYes Debt/Eq1.14 EPS Q/Q-26.70% Profit Margin19.90% Rel Volume1.70 Prev Close89.12
ShortableYes LT Debt/Eq0.94 EarningsJul 24 BMO Payout0.00% Avg Volume5.08M Price86.19
Recom1.80 SMA20-1.17% SMA505.01% SMA2009.29% Volume8,659,813 Change-3.29%
25-Apr-14Reiterated Summer Street Research Buy $205 → $184
19-Mar-14Reiterated Summer Street Research Buy $180 → $205
27-Feb-14Reiterated UBS Buy $200 → $209
28-Jan-14Reiterated Deutsche Bank Buy $170 → $190
14-Jan-14Reiterated Brean Capital Buy $191 → $233
05-Dec-13Upgrade UBS Neutral → Buy $163 → $200
28-Oct-13Reiterated Argus Buy $175
25-Oct-13Reiterated Barclays Overweight $158 → $173
26-Jul-13Reiterated Cantor Fitzgerald Buy $156
26-Jul-13Reiterated Barclays Overweight $132 → $158
26-Jul-13Reiterated Argus Hold $160
17-Jul-13Reiterated RBC Capital Mkts Outperform $130 → $145
13-Jun-13Upgrade Argus Hold → Buy $140
26-Apr-13Reiterated Barclays Overweight $113 → $132
22-Apr-13Reiterated Cantor Fitzgerald Buy $121 → $142
05-Apr-13Upgrade Deutsche Bank Hold → Buy $105 → $143
25-Mar-13Downgrade WallachBeth Buy → Hold
04-Mar-13Reiterated Cantor Fitzgerald Buy $115 → $121
12-Feb-13Reiterated Barclays Overweight $102 → $111
28-Jan-13Downgrade Argus Buy → Hold
24-Jul-14 07:06PM  Why Celgene Stock Was Down 3% Today at Motley Fool
06:58PM  [video] No Huddle Offense: Damaged stocks at CNBC
05:07PM  Celgene, Alexion Beat Estimates, But Biotechs Fall at Investor's Business Daily
05:04PM  Celgene Stock Earnings: Key Takeaways at Motley Fool
04:16PM  S&P 500 ekes out another record close: stock market live blog recap at MarketWatch
04:03PM  Stock market live blog: S&P 500 ekes out a record close; all eyes on Amazon, Pandora at MarketWatch
03:18PM  Celgene's (CELG) CEO, Robert Hugin on Q2 2014 Results - Earnings Call Transcript Seeking Alpha
12:01PM  Celgene profit rises but revised outlook disappoints Reuters
11:44AM  Biotechs beat estimates, but the Street wants more at MarketWatch
11:39AM  Video: Celgene, Alexion Earnings Top, But Stocks Fall at Investor's Business Daily
11:39AM  Video: Celgene, Alexion Earnings Top Street, But Stocks Fall at Investor's Business Daily
11:39AM  Celgene, Alexion Earnings Top Street, But Stocks Fall at Investor's Business Daily
11:26AM  Why Gilead Is A Better Buy Than This Rival at Seeking Alpha
11:10AM  Jim Cramer's Stop Trading: Consider Buying Celgene on Friday at TheStreet
10:24AM  Celgene's Narrow Beat on Second-Quarter Earnings Fails to Impress Investors; Shares Fall at Motley Fool
09:16AM  Celgene (CELG) Stock Falls After Mixed Second-Quarter Earnings at TheStreet
08:48AM  Today's Top Health Care Stocks: Alexion Pharmaceuticals, Bristol-Myers Squibb, Celgene Corp. and Eli Lilly at Motley Fool
07:50AM  Celgene profit rises 25 pct up on higher cancer drug sales Reuters
07:38AM  CELGENE CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit EDGAR Online
07:30AM  Celgene Reports Second Quarter 2014 Operating and Financial Results Business Wire
07:07AM  Q2 2014 Celgene Corp. Earnings Release - Before Market Open CCBN
01:21AM  IPO Preview: Atara Biotherapeutics at Seeking Alpha
23-Jul-14 08:05PM  Jim Cramer's 'Mad Money' Recap: Unconventional Wisdom at TheStreet
07:35PM  Jim Cramer's 'Mad Money' Recap: Unconventional Wisdom at TheStreet
06:17PM  Biogen, Gilead Earnings Crush Q2 Estimates Investor's Business Daily
04:55PM  Biogen results crush consensus at MarketWatch
02:02PM  Earnings Preview: Bristol-Myers Squibb and Celgene Corporation at Motley Fool
01:35PM  [video] Power Countdown: Biotech, social & Internet at CNBC
01:29PM  S&P 500 Aims At New High; Biotechs Gap Up In Fast Trade at Investor's Business Daily
12:20PM  Biogen's Q2 Earnings Surpass Expectations, Tecfidera Shines Zacks
11:56AM  Video: Biogen Trounces Q2 Estimates On Tecfidera at Investor's Business Daily
11:56AM  Biogen Trounces Q2 Estimates As Tecfidera Outperforms at Investor's Business Daily
10:54AM  Biogen Idec: Biggest Beat in 10 Years, Largest Leap in Eight Months at Barrons.com
09:50AM  Celgene (CELG) Is Today's Momo Momentum Stock at TheStreet
06:16AM  A Legal Test for a Drugmaker's Off-Label Cancer Treatment at BusinessWeek
22-Jul-14 03:55PM  Celgene (CELG) Set to Beat Earnings Estimates on Strong Revs Zacks
12:50PM  Will Biogen Idec Inc. (BIIB) Surprise this Earnings Season? Zacks
12:42PM  Alexion, 3 Other Top Biotechs Reporting Earnings at Investor's Business Daily
10:20AM  Will Gilead (GILD) Earnings Disappoint in Q2 as Costs Rise? Zacks
12:30AM  Celgene drug can drive HIV out of hiding -study Reuters
21-Jul-14 04:09PM  Biogen Shares Rebound As Street Has A Change Of Heart at Investor's Business Daily
18-Jul-14 03:40PM  Biotech Enters Reporting Season With Large Caps Central To Sector Performance Benzinga
08:24AM  An Open Letter To Janet Yellen: Is There A Biotech Bubble? at Forbes
17-Jul-14 10:40AM  Cramer: The Tell of When to Sell at TheStreet
09:42AM  Yellen Fire In The Biotech Theater at Forbes
07:10AM  The Tell of When to Sell TheStreet
16-Jul-14 10:53AM  Today's Market: Tech, Biotech And Social Media Stocks In The News at Seeking Alpha
15-Jul-14 02:24PM  Q2 2014 Update: My Whistler Income And Growth Portfolio at Seeking Alpha
12:57PM  Yellen Swats Down Biotech, Social Media Stocks at Fox Business
10:33AM  Facebook, Twitter slip following cautious valuation comments from Fed at theflyonthewall.com
14-Jul-14 03:45PM  Will Johnson & Johnson (JNJ) Beat this Earnings Season? Zacks
01:28PM  Biotech Better Beat EarningsOr Else at Barrons.com
09:59AM  3 Stocks Reiterated As A Buy: MDLZ, BMY, CELG at TheStreet
11-Jul-14 04:40PM  Stocks Close Higher As Biotech, Internet Stocks Gain at Investor's Business Daily
03:06PM  Gilead Sciences: The Senate Just Wrote Me a Letter at Barrons.com
02:00PM  Oncolytics Up on Patient Enrolment Completion Zacks
10-Jul-14 01:52PM  Bull rolls on, but opportunities start to dwindle at MarketWatch
10:30AM  Celgene's Otezla Disappoints in Ankylosing Spondylitis Study Zacks
10:07AM  Regeneron Picked a Heck of a Day to Announce Good News at Barrons.com
08:48AM  Celgene Gets Bad News, Shares Climb Anyway at Motley Fool
06:00AM  Jim Cramer's Top Stock Picks: WMB AA BIIB REGN CELG GILD UNUM at TheStreet
09-Jul-14 07:51PM  Is Pharmacyclics the Next Celgene? at Motley Fool
06:45PM  Celgene's Otezla fails trial Investor's Business Daily
02:06PM  Celgene Drug Misses Mark in Spinal Arthritis Study at Motley Fool
01:24PM  Celgene's arthritis drug fails a test, but company's stock rises anyway at MarketWatch
12:37PM  Two Analysts Don't See Celgene's Weak Trial Results As A Huge Setback Benzinga
12:14PM  [video] Momentum buys at CNBC
11:57AM  Celgene shares higher despite missing primary endpoint in Otezla trial at theflyonthewall.com
11:52AM  Celgene Drug Otezla Fails Trial, But Street Sanguine at Investor's Business Daily
10:31AM  Celgene: Does Failed Trial Matter? at Barrons.com
09:00AM  Wednesdays Top Biotech Stories: Celgene, AbbVie, Shire, and Sanofi at Motley Fool
07:51AM  [$$] Celgene's Phase 3 Study of Arthritis Drug Misses Target at The Wall Street Journal
07:28AM  Celgene spondylitis drug misses main goal in late-stage study Reuters
07:27AM  Celgene shares slump as late-stage trial misses goal at MarketWatch
07:04AM  Celgene says OTEZLA did not achieve primary endpoint in Phase III trial at theflyonthewall.com
07:00AM  Celgene Reports Results from the Phase III POSTURE Study Evaluating Oral OTEZLA® in Ankylosing Spondylitis Business Wire
08-Jul-14 02:42PM  Alexion Pharma Looks To Life Beyond Its Blockbuster at Investor's Business Daily
01:04PM  CELGENE CORP /DE/ Financials EDGAR Online Financials
03-Jul-14 01:14PM  Spectrum Pharma Lymphoma Drug Approved Early at Investor's Business Daily
12:38PM  Gilead Sciences: Time for an Earnings Beat? at Barrons.com
12:26PM  Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector Benzinga
09:45AM  New Lifetime High For Celgene (CELG) at TheStreet
08:41AM  Pfizer Has It All Wrong, Should Look Into New Viable Acquisitions at Seeking Alpha
02-Jul-14 06:06AM  Cramer's Mad Money - The Mother Of All Speculative Stocks (7/1/14) at Seeking Alpha
05:00AM  'Fast Money' Recap: Let Your Winning Trades Keep Running at TheStreet
01-Jul-14 06:08PM  Cramer: Six buyable themes in second half at CNBC
06:08PM  Cramer: 6 buyable themes in second half at CNBC
12:06PM  Celgene climbs after analyst spotlights underappreciated opportunities at theflyonthewall.com
11:29AM  Biotech: Buy the Trial, Sell the Approval? at Barrons.com
11:20AM  S&P, Dow rattle cage on uncharted territory at MarketWatch
10:32AM  How to play stocks in the second half at CNBC
10:32AM  How to play stocks in the second half of 2014 at CNBC
09:50AM  Today's Momo Momentum Stock To Watch: Celgene (CELG) at TheStreet
08:30AM  Celgene Corporation to Announce Second Quarter 2014 Results on July 24, 2014 Business Wire
30-Jun-14 07:00PM  Chipotle, Keurig Near Buy Points; Energy Dominates at Investor's Business Daily
05:45PM  [video] The Dow in 25 years at CNBC
04:46PM  Gilead Sciences and Celgene Corporation Have Great Growth Potential at Motley Fool
04:34PM  Markets Little Changed As The Quarter Comes To An End Benzinga
27-Jun-14 12:17PM  [video] Best time to buy Celgene, Vertex & more at CNBC
12:17PM  [video] Best time to buy Celgene, Vertex & more
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. The company's commercial stage products include REVLIMID, an oral immunomodulatory drug for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; VIDAZA, a pyrimidine nucleoside analog to treat intermediate-2 and high-risk MDS, and chronic myelomonocytic leukemia, as well as acute myeloid leukemia (AML); ABRAXANE, a solvent-free chemotherapy product for the treatment of breast, non-small cell lung, pancreatic, and gastric cancers; and POMALYST/IMNOVID for the treatment of multiple myeloma. Its commercial stage products also comprise THALOMID for the patients with multiple myeloma and for the acute treatment of the cutaneous manifestations of erythema nodosum leprosum; ISTODAX to treat cutaneous T-cell lymphoma; and FOCALIN, FOCALIN XR, and RITALIN LA products. The company's pre clinical and clinical stage products consist of OTEZLA for the treatment of psoriatic arthritis, psoriasis, and ankylosing spondylitis; CC-122 and CC-220 to treat hematological and solid tumor cancers; cellular therapies, such as PDA-001 and PDA-002 for Crohn's and peripheral arterial diseases; CC-486, to treat MDS, AML, and solid tumors; Sotatercept and ACE-536 for the treatment of anemia in patients with rare blood disorders; CC-223 and CC-115 for lymphomas, hepatocellular, and prostate cancers; and CC-292 for the treatment of chronic lymphocytic leukemia and lymphomas. It has strategic drug discovery collaboration with Abide Therapeutics to enhance the treatment paradigm for patients with immune disorders; and strategic alliance with Forma Therapeutics. Celgene Corporation was founded in 1980 and is headquartered in Summit, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MARIO ERNESTDirectorJun 16Option Exercise0.002,0550113,892Jun 16 06:57 PM
CASEY MICHAEL DDirectorJun 15Option Exercise0.001,03403,100Jun 16 06:53 PM
DRAKE RODMAN LDirectorJun 15Option Exercise0.001,034026,180Jun 16 06:54 PM
MARIO ERNESTDirectorJun 15Option Exercise0.003,1000111,837Jun 16 06:57 PM
KAPLAN GILLADirectorJun 13Option Exercise0.001,033039,754Jun 16 06:56 PM
LOUGHLIN JAMES JDirectorJun 13Option Exercise0.001,03308,509Jun 16 06:56 PM
MARIO ERNESTDirectorJun 13Option Exercise0.001,0330108,737Jun 16 06:57 PM
BARKER RICHARD WDirectorJun 13Option Exercise0.001,03302,790Jun 16 06:52 PM
DRAKE RODMAN LDirectorJun 13Option Exercise0.00516025,146Jun 16 06:54 PM
CASEY MICHAEL DDirectorJun 13Option Exercise0.001,03302,066Jun 16 06:53 PM
Friedman Michael ADirectorJun 13Option Exercise0.001,03303,099Jun 16 06:55 PM
Friedman Michael ADirectorJun 12Option Exercise0.001,03302,066Jun 16 06:55 PM
CASEY MICHAEL DDirectorJun 12Option Exercise0.001,03301,033Jun 16 06:53 PM
DRAKE RODMAN LDirectorJun 12Option Exercise0.001,033024,630Jun 16 06:54 PM
BARKER RICHARD WDirectorJun 12Option Exercise0.001,03302,066Jun 16 06:52 PM
MARIO ERNESTDirectorJun 12Option Exercise0.001,0330107,704Jun 16 06:57 PM
LOUGHLIN JAMES JDirectorJun 12Option Exercise0.001,03307,476Jun 16 06:56 PM
KAPLAN GILLADirectorJun 12Option Exercise0.001,033038,721Jun 16 06:56 PM
KAPLAN GILLADirectorJun 09Option Exercise13.6815,000205,12552,688Jun 11 04:02 PM
CASEY MICHAEL DDirectorJun 09Option Exercise13.6815,000205,12515,000Jun 11 04:01 PM
KAPLAN GILLADirectorJun 09Sale161.6215,0002,424,29437,688Jun 11 04:02 PM
FOUSE JACQUALYN Asee remarksMay 02Option Exercise0.007,800025,589May 05 06:19 PM
HUGIN ROBERT Jsee remarksMay 02Option Exercise0.0030,0000540,434May 05 06:18 PM
KARSEN PERRY Asee remarksMay 01Option Exercise59.5011,667694,18737,627May 05 06:16 PM
KARSEN PERRY Asee remarksMay 01Sale146.7811,9221,749,91125,705May 05 06:16 PM
DRAKE RODMAN LDirectorApr 30Option Exercise38.431,00038,43023,597May 02 04:47 PM
CELGENE CORP /DE/10% OwnerApr 14Buy7.00714,2865,000,0022,386,760Apr 15 04:01 PM
MARIO ERNESTDirectorApr 07Option Exercise55.386,000332,280106,671Apr 08 04:44 PM
HUGIN ROBERT Jsee remarksMar 13Option Exercise30.9095,2042,941,921568,868Mar 14 04:03 PM
CASEY MICHAEL DDirectorMar 04Option Exercise10.9712,770140,08712,770Mar 05 04:19 PM
CASEY MICHAEL DDirectorMar 04Sale162.3312,7702,072,9540Mar 05 04:19 PM
KARSEN PERRY Asee remarksMar 03Sale159.052,408382,99225,960Mar 05 04:20 PM
CASEY MICHAEL DDirectorFeb 28Option Exercise10.972,23024,4632,230Mar 04 04:08 PM
CASEY MICHAEL DDirectorFeb 28Sale164.282,230366,3350Mar 04 04:08 PM
KAPLAN GILLADirectorFeb 13Option Exercise10.9715,000164,55037,688Feb 14 04:59 PM
Daniel Thomas Osee remarksFeb 07Option Exercise59.4729,6271,761,92748,695Feb 11 04:25 PM
Daniel Thomas Osee remarksFeb 07Sale156.0029,6274,621,82419,068Feb 11 04:25 PM
MARIO ERNESTDirectorFeb 05Option Exercise62.6513,500845,761114,171Feb 06 05:31 PM
MARIO ERNESTDirectorFeb 05Sale151.8713,5002,050,284100,671Feb 06 05:31 PM
MARIO ERNESTDirectorFeb 04Option Exercise60.027,000420,140100,671Feb 06 05:31 PM
DRAKE RODMAN LDirectorJan 31Option Exercise38.432,00076,86022,597Feb 04 05:42 PM
MARIO ERNESTDirectorJan 07Option Exercise59.892,000119,78093,671Jan 09 04:01 PM
KARSEN PERRY Asee remarksDec 27Option Exercise0.007,777025,086Dec 31 04:26 PM
STEIN LAWRENCE VSee RemarksDec 27Option Exercise78.661,27199,9771,321Dec 31 04:27 PM
Daniel Thomas Osee remarksDec 27Option Exercise0.007,777023,126Dec 31 04:25 PM
Alles Mark JSee RemarksDec 27Option Exercise0.007,777028,221Dec 31 04:24 PM
STEIN LAWRENCE VSee RemarksDec 23Option Exercise78.6612,062948,79712,112Dec 24 04:04 PM
STEIN LAWRENCE VSee RemarksDec 23Sale168.1912,0622,028,68550Dec 24 04:04 PM
COX CARRIE SMITHDirectorOct 25Option Exercise52.6724,9001,311,46219,315Oct 28 05:22 PM
DRAKE RODMAN LDirectorOct 25Option Exercise38.4350019,21520,597Oct 28 05:27 PM
COX CARRIE SMITHDirectorOct 25Sale157.6718,7502,956,313565Oct 28 05:22 PM
MARIO ERNESTDirectorOct 24Option Exercise59.896,000359,34091,671Oct 28 05:29 PM
FOUSE JACQUALYN Asee remarksOct 01Option Exercise0.0016,500025,585Oct 03 04:48 PM
CELGENE CORP /DE/10% OwnerSep 24Buy15.00666,66710,000,0053,172,887Sep 26 04:16 PM
KAPLAN GILLADirectorSep 04Option Exercise11.2315,000168,41337,688Sep 05 04:01 PM
KAPLAN GILLADirectorSep 04Sale143.9215,0002,158,85722,688Sep 05 04:01 PM
Daniel Thomas Osee remarksAug 28Option Exercise64.9132,2632,094,10147,612Aug 29 09:08 PM
Daniel Thomas Osee remarksAug 28Sale137.0632,2634,421,96715,349Aug 29 09:08 PM
Daniel Thomas Osee remarksAug 20Option Exercise53.8511,142599,95815,349Aug 21 04:08 PM
MARIO ERNESTDirectorAug 14Option Exercise54.354,625251,36985,671Aug 15 04:01 PM
DRAKE RODMAN LDirectorAug 07Option Exercise38.4350019,21520,097Aug 12 04:26 PM
Alles Mark JSee RemarksAug 02Option Exercise66.4915,000997,35019,946Aug 02 05:47 PM
KARSEN PERRY Asee remarksAug 02Option Exercise45.02118,0085,312,410118,464Aug 02 05:46 PM
KARSEN PERRY Asee remarksAug 02Sale146.5093,00813,625,67212,494Aug 02 05:46 PM
Alles Mark JSee RemarksAug 02Sale146.475,000732,33514,946Aug 02 05:47 PM
Alles Mark JSee RemarksJul 31Option Exercise55.3296,4065,332,913101,352Aug 02 05:47 PM
Alles Mark JSee RemarksJul 31Sale147.0196,40614,172,6464,946Aug 02 05:47 PM
Celgene European Investment Co10% OwnerJul 29Buy18.00708,33312,749,994708,333Jul 30 11:58 AM
CVS [NYSE]
CVS Caremark Corporation
IndexS&P 500 P/E20.02 EPS (ttm)3.94 Insider Own0.10% Shs Outstand1.17B Perf Week3.65%
Market Cap92.24B Forward P/E15.68 EPS next Y5.03 Insider Trans30.90% Shs Float1.17B Perf Month4.89%
Income4.78B PEG1.43 EPS next Q1.10 Inst Own87.00% Short Float0.88% Perf Quarter8.35%
Sales128.70B P/S0.72 EPS this Y24.20% Inst Trans-0.08% Short Ratio2.61 Perf Half Y16.07%
Book/sh32.38 P/B2.44 EPS next Y12.70% ROA8.20% Target Price81.39 Perf Year29.90%
Cash/sh2.44 P/C32.39 EPS next 5Y14.01% ROE14.90% 52W Range55.47 - 79.15 Perf YTD11.49%
Dividend1.10 P/FCF29.60 EPS past 5Y10.60% ROI10.00% 52W High-0.33% Beta0.97
Dividend %1.39% Quick Ratio0.80 Sales past 5Y7.80% Gross Margin18.80% 52W Low42.22% ATR0.86
Employees130000 Current Ratio1.50 Sales Q/Q6.30% Oper. Margin6.50% RSI (14)66.24 Volatility1.17% 1.04%
OptionableYes Debt/Eq0.35 EPS Q/Q23.40% Profit Margin4.40% Rel Volume0.94 Prev Close78.13
ShortableYes LT Debt/Eq0.34 EarningsAug 05 BMO Payout20.00% Avg Volume3.93M Price78.89
Recom1.80 SMA203.19% SMA502.93% SMA20012.05% Volume3,674,443 Change0.97%
19-May-14Initiated Standpoint Research Strong Sell $62
05-May-14Reiterated Barclays Overweight $74 → $85
04-Apr-14Reiterated Argus Buy $77 → $83
22-Jan-14Upgrade ISI Group Buy → Strong Buy
19-Dec-13Reiterated RBC Capital Mkts Outperform $71 → $76
19-Dec-13Reiterated Mizuho Buy $74 → $81
19-Dec-13Reiterated FBR Capital Outperform $72 → $80
19-Dec-13Reiterated Argus Buy $70 → $77
11-Dec-13Reiterated UBS Buy $70 → $77
04-Dec-13Reiterated Mizuho Buy $70 → $74
21-Nov-13Initiated Deutsche Bank Hold $71
06-Nov-13Reiterated Mizuho Buy $66 → $70
06-Nov-13Reiterated FBR Capital Outperform $69 → $72
05-Nov-13Reiterated ISI Group Buy $67 → $70.50
24-Oct-13Initiated FBR Capital Outperform $69
07-Aug-13Downgrade Cantor Fitzgerald Buy → Hold $65 → $62
09-Jul-13Reiterated Mizuho Buy $56 → $64
24-May-13Reiterated RBC Capital Mkts Outperform $64 → $71
03-May-13Reiterated RBC Capital Mkts Outperform $59 → $64
02-May-13Reiterated Cantor Fitzgerald Buy $57 → $65
24-Jul-14 09:00PM  Moody's Assigns Rating to CVS Lease-Backed Pass-Through Series 2014 Trust at Moody's
06:23PM  Final Glance: Drugstore companies AP
04:45PM  Portfolio Management Advice for H2 2014 from a Value-Oriented, Low-Volatility Investing Genius Wall Street Transcript
03:45PM  Diagnosing CVS/Caremark Yahoo Finance Blogs
03:45PM  Diagnosing CVS/Caremark Yahoo Finance Blogs
01:23PM  Midday Glance: Drugstore companies AP
11:37AM  Early Glance: Drugstore companies AP
23-Jul-14 06:02PM  Final Glance: Drugstore companies AP
01:52PM  How Amazon stock has been outperforming rivals at CNBC
01:52PM  How Amazon stock has been 'killing' its rivals at CNBC
01:30PM  4 ways Gileads earnings will impact every American at MarketWatch
01:25PM  Midday Glance: Drugstore companies AP
12:02PM  Gileads earnings report affects every American at MarketWatch
10:32AM  Early Glance: Drugstore companies AP
22-Jul-14 06:02PM  Final Glance: Drugstore companies AP
02:02PM  Is Rite Aid the Best Pharmacy Stock? at Motley Fool
01:57PM  Midday Glance: Drugstore companies AP
21-Jul-14 06:03PM  Final Glance: Drugstore companies AP
01:31PM  CVS Minute Clinic experience is efficient and effective, but EHR interoperability isn't at Forbes
01:19PM  Midday Glance: Drugstore companies AP
11:38AM  Early Glance: Drugstore companies AP
08:00AM  CVS Caremark JAMA Commentary: New Hepatitis C Treatments Highlight Need to Control Costs of High-Priced Specialty Medications PR Newswire
18-Jul-14 03:01PM  FedEx Indicted for Shipping Drugs for Online Pharmacies Bloomberg
01:19PM  Midday Glance: Drugstore companies AP
11:14AM  Early Glance: Drugstore companies AP
17-Jul-14 02:20PM  CVS Caremark Forms Clinical Alliances to Boost Health Care Zacks
01:19PM  Midday Glance: Drugstore companies AP
11:23AM  Cold beer battle heats up in Indiana at CNNMoney.com
10:28AM  Early Glance: Drugstore companies AP
16-Jul-14 02:54PM  Midday Glance: Drugstore companies AP
12:39PM  Moody's Assigns a Provisional Rating to CVS Lease-Backed Pass-Through Series 2014 Trust at Moody's
11:11AM  Early Glance: Drugstore companies AP
08:30AM  CVS Caremark Announces New Clinical Affiliations with Four Major Health Care Providers PR Newswire
15-Jul-14 05:20PM  Why This Hedge Fund Is Excited About Walgreen at Motley Fool
03:24PM  CVS to buy South Florida Hispanic pharmacy chain AP
02:10PM  CVS Caremark to Expand with Navarro Discount Pharmacy Buyout Zacks
01:20PM  Midday Glance: Drugstore companies AP
10:56AM  Early Glance: Drugstore companies AP
10:18AM  Will CVS Caremark (CVS) Stock Be Helped By Navarro Acquisition? at TheStreet
09:00AM  CVS Caremark and IBM Announce the "Technology Solutions for Smarter Health" Program in Partnership with the National Association of Community Health Centers PR Newswire
08:09AM  Early movers: JPM, GS, JNJ, LO, TWX, TWTR & more at CNBC
14-Jul-14 04:10PM  CVS Caremark to Purchase Navarro Discount Pharmacy PR Newswire
01:29PM  Midday Glance: Drugstore companies AP
10:56AM  CVS/pharmacy Launches Exclusive radiance PLATINUM Line of Preservative-Free Vitamins and Supplements PR Newswire
10:47AM  Early Glance: Drugstore companies AP
11-Jul-14 07:03PM  Steven Romick's Top Five Stocks Gurufocus
04:30PM  Millions in Obamacare Grants Aim to Revolutionize Healthcare at Motley Fool
01:38PM  Midday Glance: Drugstore companies AP
10:30AM  Early Glance: Drugstore companies AP
06:00AM  Obama, corporate giants announce plan to boost suppliers Reuters
10-Jul-14 02:58PM  Why You Should Consider CVS Instead Of Walgreen at Seeking Alpha
02:55PM  CVS Caremark (CVS) Declares 27.5c Dividend at TheStreet
01:44PM  Midday Glance: Drugstore companies AP
12:57PM  CVS Caremark Corporation Announces Quarterly Dividend PR Newswire
11:01AM  Early Glance: Drugstore companies AP
09-Jul-14 01:36PM  Midday Glance: Drugstore companies AP
11:42AM  Why Family Dollar Cannot Compete Against Walgreen, Let Alone Wal-Mart at Seeking Alpha
10:30AM  Early Glance: Drugstore companies AP
08:00AM  MinuteClinic Named Official Sports Physical Provider Of USA Football PR Newswire
08-Jul-14 05:04PM  Is Everybody Underestimating Walgreen? at Motley Fool
03:35PM  Walgreen Co. Or CVS Caremark: Which Would You Rather? Benzinga
01:52PM  [video] How to Prevent Illness With Consumer Data at Bloomberg
01:41PM  Midday Glance: Drugstore companies AP
01:16PM  CVS Caremark joins American Heart Association to Promote Health in the Workplace PR Newswire
10:31AM  Early Glance: Drugstore companies AP
02:01AM  [$$] CVS Halts Sales of Certain Cold Medicines in West Virginia Stores at The Wall Street Journal
01:06AM  [$$] CVS Halts Sales of Certain Cold Medicines in West Virginia Stores at The Wall Street Journal
12:40AM  [$$] CVS Halts Sales of Certain Cold Medicines in West Virginia Stores at The Wall Street Journal
07-Jul-14 10:47PM  [$$] CVS Halts Sales of Certain Cold Medicines in West Virginia Stores at The Wall Street Journal
09:39PM  [$$] CVS Halts Sales of Certain Cold Medicines in West Virginia Stores at The Wall Street Journal
08:19PM  [$$] CVS Halts Sales of Certain Cold Medicines in West Virginia Stores at The Wall Street Journal
07:39PM  [$$] CVS Halts Some Sales in West Virginia at The Wall Street Journal
07:13PM  [$$] CVS Halts Some Sales in West Virginia at The Wall Street Journal
02:04PM  Will Rite Aid Keep Skyrocketing? at Motley Fool
01:24PM  Midday Glance: Drugstore companies AP
01:14PM  [$$] CVS Halts Some Sales in West Virginia at The Wall Street Journal
01:05PM  [$$] CVS Halts Sales of Certain Cold Medicines in West Virginia Stores at The Wall Street Journal
11:20AM  Rite Aid Posts Robust June Comps: Stock Moves Higher Zacks
10:38AM  Early Glance: Drugstore companies AP
06-Jul-14 01:48PM  How Urgency Will Save Hospitals at Motley Fool
06:32AM  Walgreen Vs. CVS Caremark: Comparison Of 2 Pharmacy Retail Giants at Seeking Alpha
05-Jul-14 12:01AM  [$$] Dow Jones Industrials Top 17,000 on Stellar Jobs Report at Barrons.com
03-Jul-14 05:15PM  Final Glance: Drugstore companies AP
05:02PM  Time to Invest in America's Largest Pharmacy? at Motley Fool
01:17PM  Midday Glance: Drugstore companies AP
12:35PM  Is Rite Aid's Tempo Lowered by Cautious Outlook? Zacks
11:32AM  Pharmacy sales boost major drugstores in June AP
10:30AM  Early Glance: Drugstore companies AP
09:55AM  [video] Cramer's Stop Trading: Buy RAD at CNBC
02-Jul-14 08:14PM  Jim Cramer's 'Mad Money' Recap: 5 Stocks That Have Buoyed the Dow at TheStreet
07:35PM  Jim Cramer's 'Mad Money' Recap: 5 Stocks That Have Buoyed the Dow at TheStreet
06:26PM  Cramer: This stock a real bargain at CNBC
06:25PM  [video] Pharmacy wars: RAD, CVS or WAG? at CNBC
06:02PM  Final Glance: Drugstore companies AP
01:32PM  Midday Glance: Drugstore companies AP
01:03PM  3 Services Stocks Moving The Sector Upward at TheStreet
11:33AM  Early Glance: Drugstore companies AP
01-Jul-14 06:06PM  Final Glance: Drugstore companies AP
01:22PM  Midday Glance: Drugstore companies AP
12:44PM  Rite Aid settles lawsuit for about $500,000 AP
CVS Caremark Corporation, together with its subsidiaries, provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. The Pharmacy Services segment offers pharmacy benefit management services, such as plan design and administration, formulary management, discounted drug purchase arrangements, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. The Retail Pharmacy segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, seasonal merchandise, greeting cards, and convenience foods, as well as provides photo finishing services. The company also offers infusion and enteral nutrition services. As of December 31, 2013, it operated 7,660 retail drugstores, 800 MinuteClinic retail health care clinics, 792 CVS/pharmacy stores, 25 retail specialty pharmacy stores, 11 specialty mail order pharmacies, and 4 mail order pharmacies, as well as online retail pharmacy Websites, CVS.com and Onofre.com.br. The company was founded in 1892 and is headquartered in Woonsocket, Rhode Island.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Boratto Eva CSVP, Cont & Chief Acct OfficerJul 21Option Exercise30.1622,107666,74739,870Jul 22 04:22 PM
Boratto Eva CSVP, Cont & Chief Acct OfficerJul 21Sale76.7722,1071,697,15417,763Jul 22 04:22 PM
Denton David MEVP, CFOJul 01Option Exercise32.7774,9892,457,611161,873Jul 03 04:13 PM
Denton David MEVP, CFOJul 01Sale75.8874,9895,690,16586,884Jul 03 04:13 PM
Boratto Eva CSVP, Cont & Chief Acct OfficerApr 02Option Exercise43.9517,108751,96524,391Apr 03 04:41 PM
Sussman AndrewSVP & President, MinuteClinicApr 02Option Exercise47.9819,210921,61820,138Apr 03 04:44 PM
Boratto Eva CSVP, Cont & Chief Acct OfficerApr 02Sale74.5117,1081,274,71717,737Apr 03 04:41 PM
Sussman AndrewSVP & President, MinuteClinicApr 02Sale74.0219,2101,422,0136,829Apr 03 04:44 PM
Lofberg Per GHEVP and President, CaremarkJan 03Option Exercise35.02389,18213,630,147280,466Jan 03 06:12 PM
Denton David MEVP, CFOJan 03Option Exercise34.4214,113485,76972,083Jan 03 06:14 PM
Joyner J. DavidEVP, Sales & Account ServicesJan 03Option Exercise37.33220,3858,227,813153,790Jan 03 06:20 PM
Denton David MEVP, CFOJan 03Sale70.5014,113994,96757,970Jan 03 06:14 PM
Joyner J. DavidEVP, Sales & Account ServicesJan 03Sale70.49220,38515,534,28828,540Jan 03 06:20 PM
Lofberg Per GHEVP and President, CaremarkJan 03Sale70.49389,18227,433,09346,400Jan 03 06:12 PM
Lofberg Per GHEVP and President, CaremarkJan 02Option Exercise32.98401,70613,248,264448,106Jan 03 06:12 PM
MERLO LARRY JPresident and CEOJan 02Option Exercise31.86228,8757,291,470185,078Jan 03 04:34 PM
Roberts Jonathan CEVP & President, CaremarkJan 02Option Exercise30.46162,1924,939,854131,010Jan 03 04:26 PM
MERLO LARRY JPresident and CEOJan 02Sale70.76228,87516,194,545117,033Jan 03 04:34 PM
Roberts Jonathan CEVP & President, CaremarkJan 02Sale70.61162,19211,452,37729,302Jan 03 04:26 PM
Lofberg Per GHEVP and President, CaremarkJan 02Sale70.58401,70628,352,40946,400Jan 03 06:12 PM
Bisaccia LisaSVP, Chief HR OfficerDec 10Option Exercise34.9612,057421,51320,533Dec 11 03:41 PM
Bisaccia LisaSVP, Chief HR OfficerDec 10Sale68.0012,057819,8768,476Dec 11 03:41 PM
Boratto Eva CSVP, Cont & Chief Acct OfficerNov 22Option Exercise45.076,654299,89619,332Nov 25 04:05 PM
Boratto Eva CSVP, Cont & Chief Acct OfficerNov 22Sale66.506,654442,49112,678Nov 25 04:05 PM
Bisaccia LisaSVP, Chief HR OfficerNov 21Option Exercise36.2315,299554,28323,775Nov 25 04:03 PM
Bisaccia LisaSVP, Chief HR OfficerNov 21Sale66.0015,2991,009,7348,476Nov 25 04:03 PM
Brennan Troyen AEVP, Chief Medical OfficerNov 18Option Exercise28.2635,3871,000,03771,369Nov 18 04:19 PM
Brennan Troyen AEVP, Chief Medical OfficerNov 18Sale65.6135,3872,321,62835,982Nov 18 04:19 PM
Foulkes HelenaExecutive Vice PresidentNov 14Option Exercise34.9624,114843,02542,025Nov 15 04:03 PM
Foulkes HelenaExecutive Vice PresidentNov 14Sale65.0024,1141,567,41017,911Nov 15 04:03 PM
Boratto Eva CSVP, Cont & Chief Acct OfficerNov 05Option Exercise34.966,029210,77418,707Nov 07 04:01 PM
Boratto Eva CSVP, Cont & Chief Acct OfficerNov 05Sale63.506,029382,84212,678Nov 07 04:01 PM
Boratto Eva CSVP, Cont & Chief Acct OfficerOct 18Option Exercise30.1611,053333,35823,731Oct 21 03:52 PM
Boratto Eva CSVP, Cont & Chief Acct OfficerOct 18Sale60.5011,053668,70712,678Oct 21 03:52 PM
Boratto Eva CSVP, Cont & Chief Acct OfficerOct 11Option Exercise30.1611,053333,35823,731Oct 15 04:14 PM
Boratto Eva CSVP, Cont & Chief Acct OfficerOct 11Sale59.5011,053657,65412,678Oct 15 04:14 PM
COSBY MARKEVP & President-CVS/pharmacySep 30Option Exercise35.78115,0064,114,915187,849Oct 01 04:19 PM
COSBY MARKEVP & President-CVS/pharmacySep 30Sale57.38141,8948,141,18945,955Oct 01 04:19 PM
Foulkes HelenaExecutive Vice PresidentSep 13Option Exercise36.2340,7341,475,79358,551Sep 13 04:05 PM
Foulkes HelenaExecutive Vice PresidentSep 13Sale60.0040,7342,444,04017,817Sep 13 04:05 PM
Foulkes HelenaExecutive Vice PresidentSep 12Option Exercise36.2312,812464,17930,629Sep 13 04:05 PM
Foulkes HelenaExecutive Vice PresidentSep 12Sale60.0012,812768,72017,817Sep 13 04:05 PM
Foulkes HelenaExecutive Vice PresidentSep 09Option Exercise41.1747,5681,958,37565,385Sep 11 04:19 PM
Foulkes HelenaExecutive Vice PresidentSep 09Sale58.6547,5682,789,86317,817Sep 11 04:19 PM
Sussman AndrewSVP & President, MinuteClinicSep 04Option Exercise36.969,020333,37912,983Sep 05 04:00 PM
Sussman AndrewSVP & President, MinuteClinicSep 04Sale58.369,020526,3983,963Sep 05 04:00 PM
XLV [NYSE]
Health Care Select Sector SPDR ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week2.71%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month2.60%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter7.74%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y9.67%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year24.64%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range48.08 - 62.34 Perf YTD12.75%
Dividend0.88 P/FCF- EPS past 5Y- ROI- 52W High-0.45% Beta-
Dividend %1.42% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low29.09% ATR0.61
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)60.40 Volatility0.83% 0.96%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.98 Prev Close62.19
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume5.88M Price62.06
Recom- SMA200.98% SMA503.13% SMA2009.36% Volume5,733,255 Change-0.21%
24-Jul-14 12:58PM  Zacks' Bull Of The Day: Acadia Healthcare at Seeking Alpha
08:56AM  [video] Q2 earnings scorecard... so far at CNBC
08:03AM  [video] Caterpillar CEO sees mining 'green shoots' at CNBC
07:09AM  [video] Eli Lilly looking for smaller acquisitions: CEO at CNBC
07:07AM  [video] Results hurt by patent expirations: Eli Lilly CEO at CNBC
23-Jul-14 01:45PM  The best offense are these three defensive plays Yahoo Finance
08:05AM  This is Yellen's gravest mistake at MarketWatch
07:23AM  [video] Court deals blow for Obamacare subsidies at CNBC
22-Jul-14 02:03PM  [video] State of American health care at CNBC
02:00PM  [video] Conflicting Obamacare rulings at CNBC
01:05PM  [video] What happened with Fed Obamacare rulings at CNBC
12:26PM  [video] Second court ruling favors Obamacare at CNBC
11:26AM  [video] Long way from ACA ruling having impact: Expert at CNBC
11:19AM  [video] White House: ACA ruling no impact on tax credits at CNBC
10:49AM  [video] Is ACA legislation slowly being dismantled? at CNBC
10:44AM  [video] US appeals court strikes blow against ACA subsides at CNBC
10:26AM  [video] Court deals blow to Obamacare at CNBC
21-Jul-14 03:57PM  Sector ETFs In 2014 And 2007: The Inconvenient Comparison Feels Like A Bone In The Throat at Seeking Alpha
12:06PM  3 sectors to buy as stocks sell off Yahoo Finance
18-Jul-14 02:12PM  [video] Tipster on the Hill? at CNBC
16-Jul-14 10:27AM  Investors beware: A market shock is looming Yahoo Finance
11-Jul-14 11:00AM  [video] Embracing telemedicine at CNBC
06:52AM  [video] Big pharma's big battle with Alzheimer's at CNBC
12:00AM  [video] European bank weighs on markets: Impact on your money at CNBC
10-Jul-14 02:00PM  [video] The doctor will see you now at CNBC
09-Jul-14 07:47AM  [video] Senior care at Home Instead at CNBC
08-Jul-14 06:00PM  Cramer's single most important investing rule at CNBC
07:45AM  [video] Steps to improve long-term health: Sanofi CEO at CNBC
07-Jul-14 06:29PM  Minimize losses with Cramer's trick for trading tech at CNBC
02:00PM  [video] The big threat to Obamacare you've never heard at CNBC
01:58PM  Materials Select Sector SPDR ETF: XLB's 2014 Halftime Report And Seasonality at Seeking Alpha
01:55PM  [video] Protect yourself from fake medicine at CNBC
06-Jul-14 08:52AM  Analysts Call Energy Rally, But Strike Out In Utilities at Seeking Alpha
05-Jul-14 07:30AM  This Weeks Big ETF Stories ETF Trends
03-Jul-14 01:50PM  Health Care Select Sector SPDR ETF: XLV's 2014 Halftime Report And Seasonality at Seeking Alpha
11:10AM  Utilities, Energy, Health Care Are the ETFs to Beat This Year at TheStreet
11:00AM  [video] Prescription roulette at CNBC
12:00AM  [video] Sneaker style & the office at CNBC
12:00AM  [video] Lessons in loans at CNBC
02-Jul-14 02:51PM  Wednesday Sector Leaders: Healthcare, Services at Forbes
06:51AM  [video] Big pharm wages war against Internet drug sales at CNBC
01-Jul-14 02:47PM  Tuesday Sector Leaders: Healthcare, Technology & Communications at Forbes
12:23PM  Confronting Health Care ETF ValuationsAgain ETF Trends
11:40AM  Your Best Best In The Medical Space at Investopedia
11:00AM  [video] Supreme Court decision day at CNBC
11:00AM  [video] Health care outlook at CNBC
30-Jun-14 04:34PM  [video] President Obama nominates new VA head at CNBC
02:49PM  Monday Sector Laggards: Healthcare, Industrial at Forbes
02:45PM  [video] What the Hobby Lobby ruling means for the rest of us at CNBC
02:40PM  How Obamacare Will Boost Your Portfolio at Seeking Alpha
01:50PM  [video] Second half health care outlook at CNBC
10:35AM  [video] Judge Holwell: Contraception ruling little impact to ACA at CNBC
10:20AM  [video] SCOTUS: Employers can refuse contraception coverage at CNBC
10:10AM  [video] SCOTUS: Workers can't be forced to pay union fees at CNBC
27-Jun-14 07:46AM  [video] Research's 'transformational' cures for blindness at CNBC
07:46AM  [video] Research's 'transformational' cures for blindness
07:42AM  [video] Finding the cure for blindness at CNBC
07:42AM  [video] Finding the cure for blindness
06:52AM  [video] FDA ruling a win for paraplegic community at CNBC
06:52AM  [video] FDA ruling a win for paraplegic community
26-Jun-14 03:58PM  The big Obamacare winners (hint: not patients) at CNBC
03:58PM  The big Obamacare winners (hint: not patients)
09:30AM  Health Care ETFs Outperforming Again ETF Trends
09:30AM  Health Care ETFs Outperforming Again
07:51AM  3 sectors to own this summer
25-Jun-14 01:26PM  3 sectors to own this summer
12:15PM  [video] GDP & S&P correlation zero, doesn't matter: Pro at CNBC
12:15PM  [video] GDP & S&P correlation zero, doesn't matter: Pro
10:32AM  [video] Santelli Exchange: Legacy of Obamacare at CNBC
10:32AM  [video] Santelli Exchange: Legacy of Obamacare
24-Jun-14 05:01PM  [video] Demographics, Dividends & Deals Will Keep Big Pharma Rolling at TheStreet
05:01PM  [video] Demographics, Dividends & Deals Will Keep Big Pharma Rolling
04:13PM  [video] Rising medical costs warning sign for industry: Pro at CNBC
04:13PM  [video] Rising medical costs warning sign for industry: Pro
04:11PM  [video] PWC forecasts medical costs uptick in 2015 at CNBC
04:11PM  [video] PWC forecasts medical costs uptick in 2015
03:37PM  [video] Vertex CEO on big cystic fibrosis breakthrough
02:41PM  Tuesday Sector Leaders: Healthcare, Utilities
02:17PM  [video] Yoga tax coming to DC?
01:06PM  [video] PwC study: Health care costs to rise in 2015
12:32PM  Are These Lagging ETFs Ready To Take Off?
08:45AM  There are two things wrong with this crucial sector
07:03AM  [video] Vertex's biotech breakthrough
23-Jun-14 02:26PM  [video] VA Crisis: Keeping whistleblowers safe
08:38AM  The Zacks Analyst Blog Highlights: SPDR S&P Pharmaceuticals ETF, Health Care Select Sector SPDR, Apple, Fossil and Movado Group
08:00AM  Aging stinks, so at least make some money from it
06:43AM  [video] Drug prices under pressure
20-Jun-14 01:40PM  An ETF Pair Trade For The Health Care Sector: XLV Vs. PTH at Seeking Alpha
01:40PM  An ETF Pair Trade For The Health Care Sector: XLV Vs. PTH
12:12PM  [video] HHS Secretary announces new CEO position at CNBC
12:12PM  [video] HHS Secretary announces new CEO position
11:23AM  [video] Legalized marijuana coming to New York at CNBC
11:23AM  [video] Legalized marijuana coming to New York
08:57AM  Best Of Breed Part 4: Financials And Healthcare at Seeking Alpha
08:57AM  Best Of Breed Part 4: Financials And Healthcare
07:25AM  XPH Crushing the Pharma ETFs Competition Zacks
17-Jun-14 03:51PM  [video] How Fed can 'spook' markets at CNBC
03:51PM  [video] How Fed can 'spook' markets
02:45PM  [video] Solution to backlog in legal system at CNBC
02:45PM  [video] Solution to backlog in legal system
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
CAG [NYSE]
ConAgra Foods, Inc.
IndexS&P 500 P/E44.96 EPS (ttm)0.69 Insider Own0.40% Shs Outstand422.50M Perf Week1.67%
Market Cap13.11B Forward P/E12.96 EPS next Y2.39 Insider Trans4.77% Shs Float420.45M Perf Month7.63%
Income297.30M PEG6.94 EPS next Q0.35 Inst Own69.70% Short Float1.68% Perf Quarter0.68%
Sales17.71B P/S0.74 EPS this Y-62.20% Inst Trans0.47% Short Ratio1.71 Perf Half Y-5.25%
Book/sh12.46 P/B2.49 EPS next Y6.35% ROA2.20% Target Price31.00 Perf Year-12.94%
Cash/sh0.43 P/C71.58 EPS next 5Y6.48% ROE8.20% 52W Range27.86 - 36.41 Perf YTD-6.48%
Dividend1.00 P/FCF24.87 EPS past 5Y-12.30% ROI4.20% 52W High-14.80% Beta0.49
Dividend %3.22% Quick Ratio0.70 Sales past 5Y7.50% Gross Margin20.40% 52W Low11.34% ATR0.50
Employees- Current Ratio1.60 Sales Q/Q-3.00% Oper. Margin5.60% RSI (14)55.60 Volatility1.40% 1.42%
OptionableYes Debt/Eq1.71 EPS Q/Q-268.90% Profit Margin2.50% Rel Volume1.20 Prev Close31.08
ShortableYes LT Debt/Eq1.67 EarningsJun 26 BMO Payout94.30% Avg Volume4.13M Price31.02
Recom2.80 SMA201.99% SMA50-0.20% SMA200-0.03% Volume4,955,773 Change-0.19%
12-Feb-14Reiterated Deutsche Bank Hold $35 → $31
26-Nov-13Initiated RBC Capital Mkts Sector Perform $33
11-Sep-13Reiterated Barclays Overweight $40 → $38
03-Apr-13Reiterated Deutsche Bank Hold $35 → $40
20-Feb-13Reiterated Deutsche Bank Hold $31 → $32
24-Jan-13Reiterated UBS Buy $38 → $36
28-Nov-12Reiterated Deutsche Bank Hold $29 → $31
21-Sep-12Upgrade UBS Neutral → Buy $27 → $31
25-Jul-12Initiated KeyBanc Capital Mkts Buy $30
05-May-11Reiterated Deutsche Bank Hold $23 → $28
22-Sep-10Reiterated Barclays Capital Equal Weight $27 → $25
17-Sep-10Reiterated Deutsche Bank Hold $26 → $25
22-Mar-10Reiterated Credit Suisse Neutral $24 → $27
23-Sep-09Reiterated Credit Suisse Neutral $21 → $24
23-Jun-09Upgrade UBS Neutral → Buy
15-Jun-09Downgrade Citigroup Buy → Hold
27-Mar-09Upgrade Bernstein Underperform → Mkt Perform
25-Mar-09Reiterated Credit Suisse Neutral $18 → $16
18-Dec-08Reiterated UBS Neutral $15 → $17
26-Nov-08Reiterated Barclays Capital Equal Weight $22 → $18
24-Jul-14 06:23PM  Final Glance: Food companies AP
09:41AM  CONAGRA FOODS INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
23-Jul-14 06:02PM  Final Glance: Food companies AP
06:00PM  Your first trade for Thursday at CNBC
01:04PM  CONAGRA FOODS INC /DE/ Financials EDGAR Online Financials
01:00PM  Your first trade for Thursday at CNBC
12:59PM  [video] FMHR Final Trade: ATML, KWEB & more at CNBC
22-Jul-14 06:02PM  Final Glance: Food companies AP
12:58PM  Why ConAgra Foods Should Increase Its Dividend at Motley Fool
12:03PM  Roving Butchers of Marthas Vineyard Serve Locavores Bloomberg
12:00AM  Roving Butchers of Marthas Vineyard Serve Locavores Bloomberg
21-Jul-14 06:02PM  Final Glance: Food companies AP
09:15AM  [video] Cramer: Yum lost focus at CNBC
09:04AM  Q. and A. With Stuart Elliott at New York Times
08:44AM  ConAgra Foods, Inc. Announces Notes Tender Offer Business Wire
18-Jul-14 04:13PM  CONAGRA FOODS INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
17-Jul-14 09:42AM  Should Investors Fear ConAgra's Debt Load? at Motley Fool
16-Jul-14 05:00PM  Proposed U.S. food label changes fall short, says former FDA head Reuters
03:17PM  CONAGRA FOODS INC /DE/ Files SEC form 10-K, Annual Report EDGAR Online
11:20AM  The Right and Wrong Way to Trade Corn at Minyanville
09:58AM  Lofthouse Cookies Announces Nut-Free Production Facility Business Wire
15-Jul-14 12:44PM  ConAgra Foods Announces Dividend Payment Business Wire
11:40AM  ConAgra Acquires TaiMei Potato for $93M, Extends Global Footprint Zacks
14-Jul-14 09:40AM  Is It Finally Time to Buy ConAgra? at Motley Fool
08:35AM  ConAgra buys Chinese potato processor for $93M AP
07:30AM  ConAgra Foods Acquires Chinese Potato Processor TaiMei Potato Industry Limited Business Wire
06:03AM  Earnings growth urgently needed to extend bull run at Financial Times
10-Jul-14 09:33PM  Agencies Set Sights on Marketing for a Cause at New York Times
09:33PM  Agencies Set Sights on Marketing for a Cause at New York Times
09-Jul-14 03:47PM  [video] Keeping up with consumer taste at CNBC
10:52AM  Learn From ConAgra's Forecasting Debacle: Switch To Range Forecasting at Forbes
10:52AM  Learn From ConAgra's Forecasting Debacle. Switch To Range Forecasting. at Forbes
07-Jul-14 03:58PM  Is There a Silver Lining to ConAgra Foods' Struggles? at Motley Fool
11:16AM  Hungry? 3 Stocks to Munch On Zacks
04-Jul-14 06:43AM  [$$] Consumers Cool on Packaged Goods: Cereal Acquirers at Barrons.com
03-Jul-14 05:15PM  Final Glance: Food companies AP
08:10AM  Unilever Continues to Focus on Core Business Zacks
06:21AM  Good Companies Are Horrible Shorts TheStreet
02-Jul-14 06:02PM  Final Glance: Food companies AP
09:36AM  Why ConAgra Foods Is Down 11% So Far This Year at Motley Fool
06:28AM  Pressurized Revenue And Contracted Margins Not Enough To Dampen ConAgra's Potential at Seeking Alpha
01-Jul-14 06:06PM  Final Glance: Food companies AP
30-Jun-14 06:05PM  Final Glance: Food companies AP
09:10AM  ConAgra Completes Boardman Plant Expansion Zacks
08:00AM  'Noisy' Is a Pretty Good Word for This Inflation at TheStreet
08:00AM  Cramer: 'Noisy' Is a Pretty Good Word for This Inflation at TheStreet
28-Jun-14 10:28AM  Flowers Foods: Achieving Excellence for Investors at Motley Fool
27-Jun-14 10:38PM  ConAgra: 7 Reasons Why Contrarians And Dividend Investors Should Buy The Pullback In This Cheap Stock at Seeking Alpha
10:38PM  ConAgra: 7 Reasons Why Contrarians And Dividend Investors Should Buy The Pullback In This Cheap Stock
06:02PM  Final Glance: Food companies AP
06:02PM  Final Glance: Food companies
02:30PM  ConAgra Foods Lamb Weston and Community Leaders Celebrate Boardman Plant Expansion Business Wire
02:30PM  ConAgra Foods Lamb Weston and Community Leaders Celebrate Boardman Plant Expansion
26-Jun-14 10:36PM  Revenue at Conagra Foods Is Better Than Expected at New York Times
10:36PM  Revenue at Conagra Foods Is Better Than Expected
10:36PM  Revenue at Conagra Foods Is Better Than Expected
06:03PM  Final Glance: Food companies
05:04PM  ConAgra: This Dividend Champion Will Rise Again
04:31PM  Updates, advisories and surprises
03:16PM  [video] Sector Report: Consumer Staples at Bloomberg
03:16PM  [video] Sector Report: Consumer Staples
02:32PM  Will Market Pressures Continue to Plague ConAgra Foods? at Motley Fool
02:32PM  Will Market Pressures Continue to Plague ConAgra Foods?
01:09PM  ConAgra sees recovery in private brands, consumer foods Reuters
01:09PM  ConAgra sees recovery in private brands, consumer foods
11:13AM  [video] ConAgra Says Packaged Foods a Hard Sell As Quarterly Profits Slip at TheStreet
11:13AM  [video] ConAgra Says Packaged Foods a Hard Sell As Quarterly Profits Slip
10:10AM  ConAgra sees Q1 comparable EPS slightly below year-ago levels theflyonthewall.com
10:10AM  ConAgra sees Q1 comparable EPS slightly below year-ago levels
09:45AM  ConAgra Swings to 4Q Loss on Private Label Weakness
09:34AM  ConAgra sees modest recovery in private brands unit
09:30AM  ConAgra Foods Earnings Call scheduled for 9:30 am ET today
09:20AM  ConAgra Misses on Earnings, Beats on Revenues
09:20AM  ConAgra Misses on Earnings, Beats on Revenues
09:05AM  ConAgra Posts Huge Loss on Impairment Charge
08:58AM  ConAgra sees modest recovery in private brands unit
08:32AM  [video] Why Arent Americans Spending on Groceries
08:06AM  [$$] ConAgra Swings to Quarterly Loss
08:01AM  Updates, advisories and surprises
07:55AM  ConAgras Cheap Stock May Become Activist Snack
07:55AM  ConAgra fourth-quarter revenue beats expectations
07:54AM  ConAgra could be called on to break-up, sell brands, Bloomberg says
07:49AM  ConAgra revenue beats estimates as commercial food sales rise
07:36AM  CONAGRA FOODS INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
07:34AM  ConAgra Foods Earnings Call scheduled for 9:30 am ET today
07:31AM  ConAgra committed to maintaining strong dividend policy
07:31AM  [video] Earnings News from ConAgra, Accenture; Jim Cramers Facebook Play
07:30AM  ConAgra Foods Reports Fiscal 2014 Fourth Quarter EPS; Non-Cash Impairment Charges Recognized With No Impact on Comparable EPS; Exceeds Operating Cash Flow and Debt Reduction Goals; Commitment to Strong Dividend Reaffirmed
07:07AM  Q4 2014 ConAgra Foods Earnings Release - Before Market Open
06:05AM  Stock futures flat before consumer spending, claims data
12:20AM  ConAgra Foods Earnings Call scheduled for 9:30 am ET today
12:16AM  [$$] No Prize in ConAgra's Cereal Box
25-Jun-14 10:58PM  [$$] No Prize in ConAgra's Cereal Box
09:28PM  [$$] No Prize in ConAgra's Cereal Box
07:21PM  ConAgras Cheap Stock May Become Activist Snack
07:21PM  ConAgras Cheap Stock May Become Activist Snack: Real M&A
06:09PM  Final Glance: Food companies
04:46PM  Stocks end in the green
04:46PM  Stocks bounce back and end higher
04:01PM  [$$] No Prize in ConAgra's Cereal Box
ConAgra Foods, Inc. operates as a food company primarily in North America. The company operates through three segments: Consumer Foods, Commercial Foods, and Private Brands. The Consumer Foods segment provides branded food products in various categories, such as meals, entrees, condiments, sides, snacks, and desserts to various retail channels, such as grocery and convenience stores across frozen, refrigerated, and shelf-stable temperature classes. This segment's principal brands include Alexia, ACT II, Banquet, Blue Bonnet, Chef Boyardee, DAVID, Egg Beaters, Healthy Choice, Hebrew National, Hunt's, Marie Callender's, Odom's Tennessee Pride, Orville Redenbacher's, PAM, Peter Pan, Reddi-wip, Slim Jim, Snack Pack, Swiss Miss, Van Camp's, and Wesson. The Commercial Foods segment offers food and ingredients primarily to commercial, foodservice, food manufacturing, and industrial customers. It provides frozen and sweet potato items, vegetable products, and spice and frozen bakery goods under the Lamb Weston, and Spicetec Flavors & Seasonings brand names. The Private Brands segment offers private branded and customized food items in various retail channels, including grocery and convenience stores. Its products consist of hot and ready-to-eat cereals; condiments; bars and coordinated categories; pastas; and retail bakery goods. ConAgra Foods, Inc. was founded in 1919 and is headquartered in Omaha, Nebraska.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STINSON KENNETH EDirectorJul 14Option Exercise25.779,000231,93095,465Jul 16 05:48 PM
Theophilus Nicole BEVP, Chief HR OfficerJul 14Option Exercise24.7428,000692,72061,918Jul 16 05:49 PM
STINSON KENNETH EDirectorJul 14Sale30.587,591232,13487,874Jul 16 05:48 PM
Theophilus Nicole BEVP, Chief HR OfficerJul 14Sale30.6328,000857,66533,918Jul 16 05:49 PM
Wise Robert GSVP, Corporate ControllerJul 11Option Exercise0.005,000012,229Jul 15 04:32 PM
JURGENSEN WILLIAM GDirectorJul 09Option Exercise25.779,000231,93098,907Jul 11 04:26 PM
JURGENSEN WILLIAM GDirectorJul 09Sale30.647,581232,28291,326Jul 11 04:26 PM
BUTLER STEPHEN GDirectorJul 07Option Exercise25.779,000231,93065,787Jul 09 05:07 PM
BUTLER STEPHEN GDirectorJul 07Sale30.999,000278,91056,787Jul 09 05:07 PM
McGough Thomas MPresident, Consumer FoodsJul 03Option Exercise21.2610,000212,60032,851Jul 08 05:13 PM
Batcheler ColleenEVP Gen Counsel & Corp SectyJul 03Option Exercise26.1542,0001,098,300133,705Jul 08 05:10 PM
McGough Thomas MPresident, Consumer FoodsJul 03Sale31.073,937122,32328,914Jul 08 05:13 PM
Batcheler ColleenEVP Gen Counsel & Corp SectyJul 03Sale31.0242,0001,302,84891,705Jul 08 05:10 PM
Bolles Albert D.EVP & Chief Tech & Op OfficerJul 02Sale30.3680024,2880Jul 07 04:36 PM
BAY MOGENS CDirectorJul 01Option Exercise25.779,000231,93075,281Jul 03 05:02 PM
BAY MOGENS CDirectorJul 01Sale29.677,827232,22267,454Jul 03 05:02 PM
RODKIN GARY MPresident and CEOJun 30Option Exercise26.8050,0001,340,000689,765Jul 01 07:05 PM
RODKIN GARY MPresident and CEOJun 30Sale29.3550,0001,467,360639,765Jul 01 07:05 PM
RODKIN GARY MPresident and CEOJun 23Option Exercise26.8050,0001,340,000689,765Jun 24 04:19 PM
RODKIN GARY MPresident and CEOJun 23Sale28.8450,0001,441,980639,765Jun 24 04:19 PM
RODKIN GARY MPresident and CEOJun 16Option Exercise26.8050,0001,340,000689,765Jun 17 04:40 PM
RODKIN GARY MPresident and CEOJun 16Sale32.4450,0001,622,000639,765Jun 17 04:40 PM
RODKIN GARY MPresident and CEOJun 09Option Exercise26.8050,0001,340,000689,765Jun 10 08:28 PM
RODKIN GARY MPresident and CEOJun 09Sale32.6550,0001,632,350639,765Jun 10 08:28 PM
RODKIN GARY MPresident and CEOJun 02Option Exercise26.8050,0001,340,000689,765Jun 03 04:36 PM
RODKIN GARY MPresident and CEOJun 02Sale32.1950,0001,609,295639,765Jun 03 04:36 PM
RODKIN GARY MPresident and CEOMay 27Option Exercise26.8050,0001,340,000689,765May 29 06:10 PM
RODKIN GARY MPresident and CEOMay 27Sale31.5750,0001,578,365639,765May 29 06:10 PM
RODKIN GARY MPresident and CEOMay 19Option Exercise26.8050,0001,340,000689,765May 21 04:25 PM
RODKIN GARY MPresident and CEOMay 19Sale31.2750,0001,563,550639,765May 21 04:25 PM
RODKIN GARY MPresident and CEOMay 12Option Exercise26.8050,0001,340,000689,765May 14 05:15 PM
RODKIN GARY MPresident and CEOMay 12Sale30.8350,0001,541,340639,765May 14 05:15 PM
RODKIN GARY MPresident and CEOMay 05Option Exercise26.8050,0001,340,000689,765May 07 04:30 PM
RODKIN GARY MPresident and CEOMay 05Sale30.1750,0001,508,720639,765May 07 04:30 PM
RODKIN GARY MPresident and CEOApr 28Option Exercise26.8050,0001,340,000689,765Apr 30 04:19 PM
RODKIN GARY MPresident and CEOApr 28Sale30.8650,0001,542,760639,765Apr 30 04:19 PM
Theophilus Nicole BEVP, Chief HR OfficerApr 01Option Exercise24.7420,000494,80053,918Apr 03 05:01 PM
Theophilus Nicole BEVP, Chief HR OfficerApr 01Sale30.7620,000615,23233,918Apr 03 05:01 PM
Theophilus Nicole BEVP, Chief HR OfficerMar 24Option Exercise23.9318,000430,74051,918Mar 26 04:21 PM
GREGOR JOIE ADirectorMar 24Buy30.263,30099,84733,017Mar 26 04:19 PM
Theophilus Nicole BEVP, Chief HR OfficerMar 24Sale30.1118,000541,98033,918Mar 26 04:21 PM
Ross Andrew GeorgeEVP and CSOFeb 26Option Exercise0.004,60104,601Feb 28 04:08 PM
Theophilus Nicole BEVP, Chief HR OfficerFeb 26Option Exercise0.003,068034,953Feb 28 04:10 PM
Keck Brian LEVP, CAOFeb 26Option Exercise0.003,068038,312Feb 28 04:07 PM
Gehring JohnEVP and CFOFeb 26Option Exercise0.004,6010158,129Feb 28 04:05 PM
Batcheler ColleenEVP Gen Counsel & Corp SectyFeb 26Option Exercise0.004,601093,210Feb 28 04:03 PM
Keck Brian LEVP, CAOOct 01Option Exercise0.0040,000054,024Oct 03 04:09 PM
JURGENSEN WILLIAM GDirectorSep 23Option Exercise21.349,000192,06091,073Sep 25 04:12 PM
JURGENSEN WILLIAM GDirectorSep 23Sale31.006,217192,72784,856Sep 25 04:12 PM
Gehring JohnEVP and CFOAug 12Option Exercise21.2640,000850,400193,528Aug 13 04:56 PM
Gehring JohnEVP and CFOAug 12Sale36.4940,0001,459,772153,528Aug 13 04:56 PM
GILD [NASD]
Gilead Sciences Inc.
IndexS&P 500 P/E33.41 EPS (ttm)2.71 Insider Own0.50% Shs Outstand1.54B Perf Week6.43%
Market Cap139.04B Forward P/E11.18 EPS next Y8.10 Insider Trans10.70% Shs Float1.53B Perf Month12.04%
Income4.58B PEG1.18 EPS next Q1.73 Inst Own93.10% Short Float6.14% Perf Quarter22.22%
Sales13.67B P/S10.17 EPS this Y10.40% Inst Trans-0.04% Short Ratio7.83 Perf Half Y10.21%
Book/sh8.71 P/B10.39 EPS next Y23.03% ROA19.10% Target Price102.04 Perf Year51.20%
Cash/sh4.21 P/C21.49 EPS next 5Y28.20% ROE39.20% 52W Range55.96 - 90.98 Perf YTD20.56%
Dividend- P/FCF37.73 EPS past 5Y11.90% ROI18.70% 52W High-0.48% Beta0.72
Dividend %- Quick Ratio1.80 Sales past 5Y16.00% Gross Margin77.80% 52W Low61.79% ATR2.16
Employees6100 Current Ratio2.20 Sales Q/Q97.50% Oper. Margin47.90% RSI (14)65.24 Volatility2.84% 2.50%
OptionableYes Debt/Eq0.73 EPS Q/Q209.30% Profit Margin33.50% Rel Volume1.97 Prev Close90.34
ShortableYes LT Debt/Eq0.59 EarningsJul 23 AMC Payout0.00% Avg Volume11.97M Price90.54
Recom1.70 SMA204.10% SMA508.47% SMA20018.32% Volume23,518,744 Change0.22%
24-Jul-14Reiterated RBC Capital Mkts Outperform $96 → $102
28-Apr-14Reiterated Maxim Group Buy $101 → $112
21-Feb-14Reiterated Barclays Overweight $90 → $95
10-Feb-14Reiterated Argus Buy $84 → $90
05-Feb-14Reiterated RBC Capital Mkts Outperform $90 → $96
05-Feb-14Reiterated Needham Buy $85 → $95
05-Feb-14Reiterated Maxim Group Buy $98 → $101
04-Feb-14Upgrade Robert W. Baird Neutral → Outperform $65 → $103
28-Jan-14Reiterated Deutsche Bank Buy $95 → $132
06-Jan-14Reiterated UBS Buy $80 → $102
02-Jan-14Reiterated Maxim Group Buy $89 → $98
20-Dec-13Reiterated RBC Capital Mkts Outperform $80 → $90
01-Nov-13Reiterated Argus Buy $70 → $84
30-Oct-13Reiterated RBC Capital Mkts Outperform $72 → $80
30-Oct-13Reiterated Barclays Overweight $68 → $74
26-Jul-13Reiterated Stifel Buy $65 → $75
26-Jul-13Reiterated RBC Capital Mkts Outperform $62 → $72
26-Jul-13Reiterated Barclays Overweight $65 → $68
26-Jul-13Downgrade Robert W. Baird Outperform → Neutral $55 → $65
13-Jun-13Upgrade Argus Hold → Buy
24-Jul-14 07:42PM  [$$] Beggar-Thy-Neighbor Medicine at The Wall Street Journal
07:08PM  Why Gilead Sciences, inc. Stock Was Flat Today at Motley Fool
05:07PM  Celgene, Alexion Beat Estimates, But Biotechs Fall at Investor's Business Daily
05:05PM  3 Crucial Quotes From Gilead Sciences Stock at Motley Fool
04:48PM  Understanding The Excitement That Surrounds Gilead at Seeking Alpha
04:02PM  What Gilead Stock's Latest Blockbuster Approval Means for Investors at Motley Fool
02:18PM  [$$] Hepatitis C Pill Rockets Gilead Into Big Leagues at The Wall Street Journal
02:05PM  3 Game-Changing Stories That Shook Investors: Inovio Pharmaceuticals, Gilead Sciences, and GlaxoSmithKline at Motley Fool
01:50PM  A Re-Analysis Of Gilead After Q2 Results And The Early Idelalisib Approval at Seeking Alpha
01:39PM  Your first trade for Friday at CNBC
12:59PM  [video] FMHR Final Trade: DAL, MCK, GILD & DNR at CNBC
12:30PM  Gilead: Even This Raging Bull Was Too Pessimistic at Seeking Alpha
11:44AM  Biotechs beat estimates, but the Street wants more at MarketWatch
11:39AM  Video: Celgene, Alexion Earnings Top, But Stocks Fall at Investor's Business Daily
11:39AM  Celgene, Alexion Earnings Top Street, But Stocks Fall at Investor's Business Daily
11:26AM  Why Gilead Is A Better Buy Than This Rival at Seeking Alpha
11:25AM  Gilead Sciences Q2 2014: All Is Good, More To Come At Medical Conferences Later This Year at Seeking Alpha
11:11AM  Jim Cramer's Mad Dash: Gilead Sciences Still Has Upside at TheStreet
10:29AM  This Eye-Popping Chart Of Ex-US Companies Shows Why People Are Freaking Out About 'Tax Inversions' Business Insider
10:28AM  Gilead Sciences - Sovaldi Momentum Continues, Appeal Remains at Seeking Alpha
10:00AM  Galectin, Intercept, Others Vying for Lead Drugs in NASH Epidemic Accesswire
09:45AM  Today's Momo Momentum Stock To Watch: Gilead (GILD) at TheStreet
09:43AM  Gilead: Sovaldi Delivers Q2 Product Sales Of $3.5B... Enough Said at Seeking Alpha
09:38AM  Gilead Sciences: Truly a Value Stock at Barrons.com
09:38AM  Gilead Sciences: Now Can We Call It a Value Stock? at Barrons.com
08:50AM  Gilead Crushes Q2 Earnings Estimates as Sovaldi Sales Soar Zacks
08:21AM  Update: Gilead Sciences Earnings at Seeking Alpha
08:14AM  Biotech Giant Blows Away Expectations After Selling $3.5 Billion Of Its 'Wonder Drug' Business Insider
07:25AM  Gilead price target raised to $109 from $99 at Leerink at theflyonthewall.com
06:50AM  Gilead Beats Q2 Views On Revenue Growth Lead By Sovaldi Drug Benzinga
12:24AM  [$$] Hepatitis C Pill Rockets Gilead Into Big Leagues at The Wall Street Journal
12:01AM  Patient Cures Spur Demand for $1,000 Hepatitis C Pill at Bloomberg
12:00AM  Gilead Announces New Agreement with Medicines Patent Pool for Access to Medicines in Developing World Countries Business Wire
23-Jul-14 10:58PM  Gilead Sciences' (GILD) CEO John Martin on Q2 2014 Results - Earnings Call Transcript Seeking Alpha
10:42PM  [$$] Hepatitis C Pill Rockets Gilead Into Big Leagues at The Wall Street Journal
09:47PM  Gilead Stock's Great Expectations and Giant Opportunity at Motley Fool
09:02PM  Gilead reports $5.8 billion in sales of hepatitis C drug at Los Angeles Times
08:51PM  [$$] Hepatitis C Pill Rockets Gilead Into Big Leagues at The Wall Street Journal
08:32PM  Gilead Sciences Crushes Second-Quarter Earnings at Motley Fool
08:00PM  [$$] Hepatitis C Pill Rockets Gilead Into Big Leagues at The Wall Street Journal
07:52PM  [$$] Hepatitis C Pill Rockets Gilead Into Big Leagues at The Wall Street Journal
06:59PM  Gilead profit more than quadruples on hep C drug AP
06:50PM  Gilead hepatitis C drug Sovaldi racks up $3.5 bln in quarter Reuters
06:32PM  Biz Break: Gilead raking in massive cash from hepatitis C drug Sovaldi at San Jose Mercury News
06:21PM  [video] Gilead Sciences Beats Street and Sees Sovaldi Sales Double at TheStreet
06:17PM  Biogen, Gilead Earnings Crush Q2 Estimates Investor's Business Daily
06:11PM  Is Gilead About to Crush Pharmacyclics Stock? at Motley Fool
06:02PM  [video] New Yorks Credit Rating Raised to AA+ by S&P at Bloomberg
05:49PM  Gilead trounces earnings views, but shares don't feel the after-hours love at MarketWatch
05:44PM  Gilead Sovaldi $3.5 Billion: The Most Important Number in Biotech Earnings Season at TheStreet
05:24PM  How Will Gilead Sciences (GILD) Stock Be Affected By Its Second Quarter Earnings Results? at TheStreet
05:16PM  Gilead Cures 9,000 Hep C Patientsand Collects $5.7 Billion at BusinessWeek
05:14PM  [video] Big Beat for Gilead on Rising Sovaldi Revenue at Bloomberg
05:12PM  [video] Why Gilead isn't soaring at CNBC
05:11PM  Gilead 2Q profit more than quadruples AP
04:54PM  Health insurer group asks Gilead to cut hepatitis C drug price Reuters
04:52PM  Gilead hepatitis C drug Sovaldi racks up $3.5 bln in quarter Reuters
04:41PM  You Just Wont Believe Gileads Profit Margins at 24/7 Wall St.
04:39PM  [$$] Hepatitis Drug Continues Record Sales at The Wall Street Journal
04:35PM  Gilead Doubles 2014 Revenue Forecast on Sovaldi Sales at Bloomberg
04:31PM  Gilead Sciences Beats Earnings Forecasts, Sovaldi Sales Strong, Shares Slump at Barrons.com
04:30PM  Gilead Sciences Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:18PM  Gilead Sciences Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:18PM  Sales of Gilead hepatitis C drug Sovaldi soar in 2nd quarter Reuters
04:17PM  Gilead trounces estimates for earnings, sales, Sovaldi at MarketWatch
04:15PM  [$$] Hepatitis Drug Continues Record Sales at The Wall Street Journal
04:12PM  [video] Gilead's big Q2 beat at CNBC
04:09PM  GILEAD SCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib EDGAR Online
04:09PM  Gilead Sovaldi $3.5 Billion: The Most Important Number in Biotech Earnings Season at TheStreet
04:05PM  Gilead earnings beat Wall Street estimates at CNBC
04:05PM  Gilead Sciences Announces Second Quarter 2014 Financial Results Business Wire
03:39PM  FDA approves Gilead Sciences drug for 3 cancers AP
02:27PM  This Is What Happens When A New Drug Hits The Market And Nobody Knows What To Expect at Seeking Alpha
02:21PM  U.S. FDA approves Gilead blood cancer drug Zydelig Reuters
02:16PM  Does the Gilead Whisper Number Indicate Earnings Confidence? at Wall St. Cheat Sheet
01:30PM  4 ways Gileads earnings will impact every American at MarketWatch
01:18PM  Gilead's moment of truth arrives: How does Sovaldi impact earnings? at MarketWatch
12:57PM  FDA approves Gilead Sciences drug for 3 cancers AP
12:40PM  [video] Biotech blowout: Biogen & Gilead at CNBC
12:02PM  Gileads earnings report affects every American at MarketWatch
11:56AM  Biogen Trounces Q2 Estimates As Tecfidera Outperforms at Investor's Business Daily
11:48AM  U.S. Food and Drug Administration Approves Gileads Zydelig® (idelalisib) for Relapsed Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small Lymphocytic Lymphoma Business Wire
11:40AM  FDA approves Zydelig for three types of blood cancers at theflyonthewall.com
08:45AM  Top Biotechnology Stocks Accesswire
07:50AM  Gilead Earnings Preview: Non-Sovaldi Sales Bogey Of $2.94B May Be Unrealistic at Seeking Alpha
07:50AM  Gilead Earnings Preview: Non-Sovaldi Sales Bogey May Be Unrealistic at Seeking Alpha
07:30AM  Stocks To Watch: Natus Medical, Gilead... at Seeking Alpha
07:07AM  Q2 2014 Gilead Sciences Earnings Release - 4:05 pm ET CCBN
22-Jul-14 07:08PM  This is What Happens When A New Drug Hits the Market and Nobody Knows What to Expect Yahoo Finance Blogs
07:08PM  This is What Happens When A New Drug Hits the Market and Nobody Knows What to Expect Yahoo Finance Blogs
05:17PM  [video] Earnings Preview: 3 Things to Watch at Bloomberg
05:03PM  Gilead Sciences Should Report $4B In Sovaldi Sales In Q2'14 at Seeking Alpha
05:02PM  3 Things You Need to Watch on Gilead Sciences Inc. Earnings Call at Motley Fool
03:20PM  Gilead's Pipeline Requires MacroGenics' ImmunoOncology Platform (M&A) at Seeking Alpha
02:29PM  What to Watch in The Day Ahead; Wednesday, July 23 Reuters
12:42PM  Alexion, 3 Other Top Biotechs Reporting Earnings at Investor's Business Daily
12:12PM  Gilead Expected to Post Sky-High Hep C Sales in June Quarter at TheStreet
11:38AM  Do This Drug's Sales Make J&J a Hepatitis C Powerhouse? at Motley Fool
10:37AM  HIV pills show more promise to prevent infection AP
10:20AM  Will Gilead (GILD) Earnings Disappoint in Q2 as Costs Rise? Zacks
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. The company's products include Stribild, Complera/Eviplera, Atripla, Truvada, Viread, Emtriva, Tybost, and Vitekta for the treatment of human immunodeficiency virus (HIV) infection in adults; and Sovaldi, Viread, and Hepsera products for the treatment of liver disease. It also offers Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa, a tablet used for the treatment of chronic angina; Lexiscan/Rapiscan injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging; Cayston, an inhaled antibiotic for the treatment of respiratory systems in cystic fibrosis patients; and Tamiflu, an oral antiviral capsule for the treatment and prevention of influenza A and B. In addition, the company provides other products, such as AmBisome, an antifungal agent to treat serious invasive fungal infections; Vistide, an antiviral injection for the treatment of cytomegalovirus retinitis in adult patients with AIDS; and Macugen, an anti-angiogenic oligonucleotide to treat neovascular age-related macular degeneration. Further, it has product candidates in various stages for the treatment of HIV, liver, oncology/inflammation, cardiovascular, and respiratory diseases. The company markets its products through its commercial teams and/or in conjunction with third-party distributors and corporate partners. Gilead Sciences, Inc. has collaborations with BMS, Janssen, and Japan Tobacco to develop and commercialize various products. The company was founded in 1987 and is headquartered in Foster City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cogan John FrancisDirectorJul 21Option Exercise14.345,00071,68847,405Jul 23 01:31 PM
Cogan John FrancisDirectorJul 21Sale89.675,000448,34342,405Jul 23 01:31 PM
Carter Paul RutherfordEVP Commercial OpsJul 08Option Exercise26.9916,728451,48947,433Jul 10 01:41 PM
Carter Paul RutherfordEVP Commercial OpsJul 08Sale86.4516,7281,446,07430,705Jul 10 01:41 PM
Whitley Richard JamesDirectorJul 01Option Exercise26.995,000134,95020,641Jul 02 04:24 PM
MARTIN JOHN CChairman and CEOJul 01Option Exercise8.01140,6251,125,7034,570,012Jul 03 02:28 PM
Alton Gregg HEVP, Corp & Med AffairsJul 01Option Exercise23.6131,000731,853159,694Jul 03 03:14 PM
Alton Gregg HEVP, Corp & Med AffairsJul 01Sale84.1233,0002,776,076126,694Jul 03 03:14 PM
MARTIN JOHN CChairman and CEOJul 01Sale84.84140,62511,929,9614,429,387Jul 03 02:28 PM
Whitley Richard JamesDirectorJul 01Sale83.655,000418,25015,641Jul 02 04:24 PM
Washington Robin LEVP, CFOJun 30Sale83.9810,400873,40346,774Jul 02 01:44 PM
Cogan John FrancisDirectorJun 23Option Exercise14.345,00071,68847,405Jun 25 01:51 PM
Cogan John FrancisDirectorJun 23Sale81.825,000409,12342,405Jun 25 01:51 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOJun 16Option Exercise16.4090,0001,475,550209,302Jun 18 04:33 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOJun 16Sale80.9090,0007,280,784119,302Jun 18 04:33 PM
Carter Paul RutherfordEVP Commercial OpsJun 09Option Exercise26.9916,728451,48947,433Jun 11 12:59 PM
Carter Paul RutherfordEVP Commercial OpsJun 09Sale79.4316,7281,328,64530,705Jun 11 12:59 PM
Washington Robin LEVP, CFOJun 04Sale82.526,426530,27457,174Jun 05 05:46 PM
Whitley Richard JamesDirectorJun 02Option Exercise26.995,000134,95020,641Jun 04 05:18 PM
Alton Gregg HEVP, Corp & Med AffairsJun 02Option Exercise23.6031,000731,600161,694Jun 04 05:21 PM
MARTIN JOHN CChairman and CEOJun 02Option Exercise8.01140,6251,125,7034,570,012Jun 04 02:48 PM
Whitley Richard JamesDirectorJun 02Sale80.955,000404,75015,641Jun 04 05:18 PM
Alton Gregg HEVP, Corp & Med AffairsJun 02Sale81.3533,0002,684,514128,694Jun 04 05:21 PM
MARTIN JOHN CChairman and CEOJun 02Sale81.32140,62511,435,8364,429,387Jun 04 02:48 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOMay 14Option Exercise16.4090,0001,475,550209,302May 16 02:52 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOMay 14Sale80.6590,0007,258,752119,302May 16 02:52 PM
Carter Paul RutherfordEVP Commercial OpsMay 10Option Exercise0.005,000021,290May 13 02:27 PM
Alton Gregg HEVP, Corp & Med AffairsMay 08Option Exercise23.3340,000933,132170,694May 12 03:38 PM
MILLIGAN JOHN FPresident and COOMay 08Option Exercise8.01100,000800,5001,038,048May 09 06:58 PM
Alton Gregg HEVP, Corp & Med AffairsMay 08Sale80.0040,0003,200,000130,694May 12 03:38 PM
Washington Robin LEVP, CFOMay 06Option Exercise24.913,00074,71552,832May 08 07:13 PM
Washington Robin LEVP, CFOMay 06Sale79.913,000239,73049,832May 08 07:13 PM
Alton Gregg HEVP, Corp & Med AffairsMay 01Option Exercise21.5811,000237,325143,694May 05 05:23 PM
Whitley Richard JamesDirectorMay 01Option Exercise26.995,000134,95017,778May 05 05:36 PM
MARTIN JOHN CChairman and CEOMay 01Option Exercise8.01140,6251,125,7034,570,012May 05 05:52 PM
MARTIN JOHN CChairman and CEOMay 01Sale79.02140,62511,112,0344,429,387May 05 05:52 PM
Whitley Richard JamesDirectorMay 01Sale78.635,000393,15012,778May 05 05:36 PM
Alton Gregg HEVP, Corp & Med AffairsMay 01Sale79.0813,0001,028,024130,694May 05 05:23 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOApr 14Option Exercise16.4090,0001,475,550209,302Apr 16 12:34 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOApr 14Sale67.0390,0006,032,482119,302Apr 16 12:34 PM
Cogan John FrancisDirectorApr 08Option Exercise14.345,00071,68844,542Apr 10 02:52 PM
Carter Paul RutherfordEVP Commercial OpsApr 08Option Exercise24.4316,728408,68945,290Apr 10 03:52 PM
Cogan John FrancisDirectorApr 08Sale70.555,000352,75539,542Apr 10 02:52 PM
Carter Paul RutherfordEVP Commercial OpsApr 08Sale70.5316,7281,179,78228,562Apr 10 03:52 PM
MARTIN JOHN CChairman and CEOApr 01Option Exercise8.01140,6251,125,7034,570,012Apr 03 03:20 PM
Alton Gregg HEVP, Corp & Med AffairsApr 01Option Exercise21.5811,000237,325145,694Apr 03 03:20 PM
Whitley Richard JamesDirectorApr 01Option Exercise26.995,000134,95018,116Apr 03 04:00 PM
Alton Gregg HEVP, Corp & Med AffairsApr 01Sale73.2013,000951,640132,694Apr 03 03:20 PM
MARTIN JOHN CChairman and CEOApr 01Sale73.26140,62510,302,0284,429,387Apr 03 03:20 PM
Whitley Richard JamesDirectorApr 01Sale73.095,000365,45013,116Apr 03 04:00 PM
Cogan John FrancisDirectorMar 14Option Exercise14.3414,000200,72553,542Mar 18 12:56 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOMar 14Option Exercise16.4090,0001,475,550209,302Mar 18 01:36 PM
Cogan John FrancisDirectorMar 14Sale76.4414,0001,070,10139,542Mar 18 12:56 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOMar 14Sale75.8990,0006,829,705119,302Mar 18 01:36 PM
Carter Paul RutherfordEVP Commercial OpsMar 10Option Exercise21.5816,728360,90745,290Mar 12 01:39 PM
Carter Paul RutherfordEVP Commercial OpsMar 10Sale79.3216,7281,326,83328,562Mar 12 01:39 PM
Alton Gregg HEVP, Corp & Med AffairsMar 03Option Exercise21.5831,000668,825117,484Mar 05 02:50 PM
MARTIN JOHN CChairman and CEOMar 03Option Exercise8.01140,6251,125,7034,397,860Mar 05 02:51 PM
MARTIN JOHN CChairman and CEOMar 03Sale81.74140,62511,495,3264,257,235Mar 05 02:51 PM
Alton Gregg HEVP, Corp & Med AffairsMar 03Sale81.8433,0002,700,68784,484Mar 05 02:50 PM
Washington Robin LEVP, CFOFeb 28Option Exercise22.3030,600682,49080,432Mar 04 09:09 PM
Carter Paul RutherfordEVP Commercial OpsFeb 28Option Exercise24.0099,0002,375,550114,842Mar 04 02:56 PM
Carter Paul RutherfordEVP Commercial OpsFeb 28Sale83.5599,0008,271,93515,842Mar 04 02:56 PM
Washington Robin LEVP, CFOFeb 28Sale83.6530,6002,559,63549,832Mar 04 09:09 PM
MOORE NICHOLAS GDirectorFeb 26Option Exercise26.6220,000532,30020,000Feb 28 12:50 PM
MOORE NICHOLAS GDirectorFeb 26Sale84.0520,0001,681,0700Feb 28 12:50 PM
Washington Robin LEVP, CFOFeb 21Option Exercise23.605,000118,00054,832Feb 25 03:41 PM
Washington Robin LEVP, CFOFeb 21Sale83.245,000416,21849,832Feb 25 03:41 PM
MOORE NICHOLAS GDirectorFeb 19Option Exercise22.0219,068419,78219,068Feb 21 02:32 PM
MOORE NICHOLAS GDirectorFeb 19Sale83.1219,0681,584,9900Feb 21 02:32 PM
Washington Robin LEVP, CFOFeb 19Sale83.3696880,69249,832Feb 21 03:41 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOFeb 14Option Exercise14.5090,0001,305,225158,124Feb 19 02:09 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOFeb 14Sale81.3690,0007,322,22268,124Feb 19 02:09 PM
Carter Paul RutherfordEVP Commercial OpsFeb 10Option Exercise21.5816,728360,90731,861Feb 12 04:44 PM
Carter Paul RutherfordEVP Commercial OpsFeb 10Sale79.1016,7281,323,19815,133Feb 12 04:44 PM
Alton Gregg HEVP, Corp & Med AffairsFeb 03Option Exercise21.5831,000668,825118,516Feb 05 06:34 PM
MARTIN JOHN CChairman and CEOFeb 03Option Exercise8.01140,6251,125,7034,396,892Feb 05 06:53 PM
Alton Gregg HEVP, Corp & Med AffairsFeb 03Sale80.7833,0002,665,59385,516Feb 05 06:34 PM
MARTIN JOHN CChairman and CEOFeb 03Sale79.96140,62511,244,0894,256,267Feb 05 06:53 PM
YOUNG KEVINEVP, Commercial OperationsJan 23Option Exercise16.40100,0001,639,500316,418Jan 27 08:07 PM
YOUNG KEVINEVP, Commercial OperationsJan 23Sale81.44100,0008,144,150216,418Jan 27 08:07 PM
Alton Gregg HEVP, Corp & Med AffairsJan 21Option Exercise19.94120,0002,392,393152,938Jan 22 07:15 PM
Alton Gregg HEVP, Corp & Med AffairsJan 21Sale80.00120,0009,600,00032,938Jan 22 07:15 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOJan 14Option Exercise14.5090,0001,305,22590,000Jan 16 02:15 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOJan 14Sale74.2390,0006,681,1470Jan 16 02:15 PM
Alton Gregg HEVP, Corp & Med AffairsJan 02Option Exercise19.11111,0002,121,519145,938Jan 06 05:39 PM
MARTIN JOHN CChairman and CEOJan 02Option Exercise8.01140,6251,125,7034,197,746Jan 06 05:38 PM
Washington Robin LSVP, CFOJan 02Option Exercise22.4935,600800,49035,600Jan 06 05:39 PM
Alton Gregg HEVP, Corp & Med AffairsJan 02Sale75.01113,0008,476,56432,938Jan 06 05:39 PM
MARTIN JOHN CChairman and CEOJan 02Sale75.02140,62510,550,1804,057,121Jan 06 05:38 PM
Washington Robin LSVP, CFOJan 02Sale75.0335,6002,671,2140Jan 06 05:39 PM
YOUNG KEVINEVP, Commercial OperationsDec 20Option Exercise16.4075,0001,229,625236,840Dec 24 01:41 PM
YOUNG KEVINEVP, Commercial OperationsDec 20Sale74.1975,0005,564,453161,840Dec 24 01:41 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSODec 16Option Exercise14.5090,0001,305,22590,000Dec 18 02:16 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSODec 16Sale71.7590,0006,457,9410Dec 18 02:16 PM
MARTIN JOHN CChairman and CEODec 02Option Exercise7.63282,2422,154,2124,339,363Dec 04 03:55 PM
MARTIN JOHN CChairman and CEODec 02Sale74.26282,24220,960,6974,057,121Dec 04 03:55 PM
MILLIGAN JOHN FPresident and COONov 25Option Exercise7.8125,588199,954590,362Nov 26 06:20 PM
YOUNG KEVINEVP, Commercial OperationsNov 22Option Exercise16.4075,0001,229,625236,840Nov 25 03:25 PM
YOUNG KEVINEVP, Commercial OperationsNov 22Sale74.3475,0005,575,549161,840Nov 25 03:25 PM
V [NYSE]
Visa Inc.
IndexDJIA S&P500 P/E26.36 EPS (ttm)8.45 Insider Own0.10% Shs Outstand628.38M Perf Week2.23%
Market Cap139.97B Forward P/E21.43 EPS next Y10.39 Insider Trans5.90% Shs Float498.68M Perf Month7.19%
Income5.40B PEG1.54 EPS next Q2.10 Inst Own91.60% Short Float3.18% Perf Quarter6.57%
Sales12.29B P/S11.39 EPS this Y140.20% Inst Trans-0.04% Short Ratio6.05 Perf Half Y-2.05%
Book/sh43.32 P/B5.14 EPS next Y15.62% ROA14.90% Target Price250.38 Perf Year20.17%
Cash/sh7.03 P/C31.69 EPS next 5Y17.10% ROE20.00% 52W Range169.71 - 234.64 Perf YTD0.40%
Dividend1.60 P/FCF22.36 EPS past 5Y52.80% ROI18.40% 52W High-5.07% Beta0.78
Dividend %0.72% Quick Ratio1.70 Sales past 5Y13.50% Gross Margin- 52W Low31.25% ATR2.91
Employees9500 Current Ratio1.70 Sales Q/Q-45.50% Oper. Margin62.70% RSI (14)65.11 Volatility0.95% 1.26%
OptionableYes Debt/Eq0.00 EPS Q/Q-34.20% Profit Margin43.90% Rel Volume1.02 Prev Close221.20
ShortableYes LT Debt/Eq0.00 EarningsJul 24 AMC Payout17.20% Avg Volume2.62M Price222.74
Recom1.80 SMA202.89% SMA504.38% SMA2005.41% Volume2,670,981 Change0.70%
25-Apr-14Reiterated RBC Capital Mkts Outperform $263 → $250
14-Apr-14Upgrade Robert W. Baird Neutral → Outperform $245
14-Apr-14Initiated Pacific Crest Outperform $241
31-Jan-14Reiterated FBR Capital Mkt Perform $210 → $250
21-Jan-14Reiterated Stifel Buy $255 → $292
16-Jan-14Reiterated Barclays Overweight $240 → $270
31-Oct-13Reiterated FBR Capital Mkt Perform $190 → $210
28-Oct-13Reiterated Barclays Overweight $215 → $240
02-Aug-13Reiterated Stifel Buy $217
25-Jul-13Reiterated UBS Neutral $199 → $202
25-Jul-13Reiterated Stifel Buy $205 → $217
25-Jul-13Reiterated RBC Capital Mkts Outperform $186 → $207
25-Jul-13Reiterated FBR Capital Mkt Perform $180 → $190
04-Jun-13Reiterated Oppenheimer Outperform $177 → $200
02-May-13Reiterated UBS Neutral $156 → $166
02-May-13Reiterated RBC Capital Mkts Outperform $176 → $186
02-May-13Reiterated FBR Capital Mkt Perform $170 → $180
02-May-13Reiterated Barclays Overweight $180 → $185
01-Mar-13Downgrade Argus Buy → Hold
21-Feb-13Upgrade UBS Sell → Neutral $123 → $156
25-Jul-14 12:02AM  [$$] Visa Earnings Gain On Strong Global Payments Volume at The Wall Street Journal
24-Jul-14 11:04PM  [$$] Visa Earnings Gain On Strong Global Payments Volume at The Wall Street Journal
09:46PM  Visa's (V) CEO Charles Scharf on Q3 2014 Results - Earnings Call Transcript Seeking Alpha
09:09PM  [$$] Visa Earnings Gain On Strong Global Payments Volume at The Wall Street Journal
07:36PM  Visa posts higher 3Q profit, revenue AP
07:26PM  [$$] Visa Profit Rises at The Wall Street Journal
06:35PM  Visa cuts revenue forecast as cross-border transactions slow Reuters
06:23PM  Visa posts higher 3Q profit, revenue AP
05:54PM  Visa Inc. Tops Expectations as Earnings Jump 15% at Motley Fool
05:36PM  Visa posts higher 3Q profit, revenue AP
05:19PM  Visa 3Q profit rises 11% at USA TODAY
05:12PM  Visa Shares Dip Following Q3 Earnings Benzinga
04:54PM  Visa Profit Pops As Consumers Choose Credit Over Cash at Forbes
04:52PM  Visa Lowers Revenue Estimates as Profit Beats Estimates at Bloomberg
04:50PM  Visa cuts revenue growth target for the year; shares fall Reuters
04:49PM  Visa 3Q profit rises 11 percent AP
04:31PM  [$$] Visa Profit Rises at The Wall Street Journal
04:23PM  Visa (V) Stock Falls in After-Hours Trading Despite Earnings Beat at TheStreet
04:21PM  Visa Profit Beats Expectations, But Stock Falls Business Insider
04:15PM  VISA INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:13PM  Visa quarterly profit rises 11 pct on card growth Reuters
04:09PM  Visa Profit Beats Estimates as Card Spending Climbs at Bloomberg
04:05PM  Visa earnings: $2.17 per share, vs. expected EPS of $2.10 a share at CNBC
04:05PM  Visa Inc. Reports Fiscal Third Quarter 2014 Net Income of $1.4 Billion or $2.17 Per Diluted Share Business Wire
04:05PM  [video] Visa Q3 profits strong at CNBC
04:00PM  Visa Posts 3Q EPS Beat at Fox Business
04:00PM  MARKETS GO NOWHERE, FACEBOOK SURGES: Here's What You Need To Know Business Insider
03:29PM  Notable companies reporting after market close at theflyonthewall.com
02:07PM  Earnings Preview: Visa to report results amid credit metric improvements at theflyonthewall.com
12:41PM  Visa invests in wireless credit card maker LoopPay paidContent.org
11:06AM  Why Visa Will Move the Dow Tomorrow at Motley Fool
10:11AM  US yields rise, rattled by jobless claims plunge at CNBC
08:41AM  US yields rise, rattled by jobless claims plunge at CNBC
08:40AM  Ford earnings, jobless claims to lift Wall Street at CNBC
08:00AM  Visa Enables Internet-Connected Devices to Become Secure Commerce Vehicles Business Wire
07:55AM  The Zacks Analyst Blog Highlights: Caterpillar, Lincoln Electric Holdings, Precision Castparts, Graphic Packaging Holding and Visa Zacks
07:07AM  Q3 2014 Visa Inc. Earnings Release - After Market Close CCBN
05:33AM  US bonds decline despite Ukraine, Gaza fears at CNBC
03:48AM  Here's Why Revenue Growth Is Expected To Slow At Visa at Seeking Alpha
23-Jul-14 06:47PM  Here's Why Revenue Growth is Expected to Slow at Visa Yahoo Finance Blogs
04:16PM  VISA INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04:05PM  Visa Inc. Declares Quarterly Dividend Business Wire
02:53PM  What to Watch in The Day Ahead; Thursday, July 24 Reuters
02:22PM  Massive Change Could Be Coming at American Express Company at Motley Fool
02:17PM  Earnings Preview: Visa Q3 2014 at Seeking Alpha
09:57AM  3 Things to Watch Carefully at Visa Inc. at Motley Fool
09:30AM  Total System Q2 Earnings Rise Y/Y on Increased Revenues Zacks
08:18AM  The Zacks Analyst Blog Highlights: Apple, Microsoft, Visa, Qiwi and Moody's Zacks
06:53AM  Is a Surprise Coming for Visa (V) This Earnings Season? Zacks
06:02AM  How Worried Should Visa And MasterCards Shareholders Be Right Now? at Motley Fool
22-Jul-14 05:45PM  Can Visa (V) Beat Q3 Earnings Estimates on Better Business? Zacks
03:46PM  Visa's Stock Is Expensive and as Cold as Russia's Winter at TheStreet
08:16AM  Canadian Pacific Railway, PriceSmart, Visa, FTI Consulting and Iron Mountain highlighted as Zacks Bull and Bear of the Day Zacks
08:14AM  Visa Earnings: Can the Card Giant Charge Higher? at Motley Fool
21-Jul-14 05:00PM  Will Nasdaq (NDAQ) Miss Earnings Estimates on Lower Volumes? Zacks
04:33PM  Investors should give Visa more credit Talking Numbers
02:30PM  Gad: The Next Google-Like IPO at TheStreet
01:36PM  SmartMetric files patent infringement suit against Visa, MasterCard theflyonthewall.com
01:34PM  [video] The fee-conomy at CNBC
01:23PM  [video] US companies in Russia at CNBC
12:30PM  3 Trending Business Services Stocks Likely to Top in Q2 Zacks
11:17AM  Why Visa (V) Stock Is Slipping Today at TheStreet
09:59AM  3 Stocks Reiterated As A Buy: QCOM, V, UTX at TheStreet
08:53AM  [video] Cramer's stocks to watch: AGN & VRX at CNBC
08:42AM  What Could Visa Inc's New Product Mean To the Payments Industry? at Motley Fool
18-Jul-14 04:43PM  Visa, MasterCard Must Face Target, Macys Swipe-Fee Case at Bloomberg
04:17PM  Stocks end with weekly gains as Ukraine tensions ebb at CNBC
04:10PM  Stocks end with weekly gains as Ukraine tensions ebb at CNBC
04:01PM  The 4 Stocks That Lifted the Market at 24/7 Wall St.
03:18PM  Stocks rise on earnings; Google boosts tech sector at CNBC
01:34PM  Why Visa Is Rallying the Dow Jones Today at Motley Fool
10:00AM  Dow Today: Visa (V) Leads The Day Higher, General Electric (GE) Lags at TheStreet
02:52AM  ESPN will broadcast a $10 million gaming tournament this weekend at Engadget
17-Jul-14 04:30PM  Dow Today: Visa (V) Lags at TheStreet
01:23PM  Squawking Murdoch media moves & Delivering Alpha at CNBC
01:22PM  Jim Cramer's Stop Trading: How Sanctions Against Russia Impact Visa, Mastercard at TheStreet
12:30PM  Alliance Data Strong Segments Aid Q2 Earnings Beat, View Up Zacks
12:29PM  Will Visa (V) Stock Be Affected By The Launch of Visa Checkout? at TheStreet
11:11AM  [video] Visa launches PayPal competitor at CNBC
06:31AM  Russia's Gazprombank see no sanctions impact on operations Reuters
03:19AM  Visa, MasterCard say new sanctions not affecting Russian operations Reuters
16-Jul-14 06:18PM  Visa Launches PayPal-Like Checkout Widget For Third-Party Websites at TechCrunch
05:13PM  Visa's latest stab at online payments is all about checking out faster at Engadget
04:17PM  Visa shows off new online payments service called Checkout at San Jose Mercury News
03:22PM  Why Visa (V) Stock Is Up Today at TheStreet
03:22PM  A New Way to Pay Online: Visa Launches 'Visa Checkout' Entrepreneur
02:52PM  Visa launches new service to pay online AP
02:35PM  Visa Opens San Francisco Technology Center to Advance Innovation in Payments Business Wire
02:32PM  The Only Reason I Don't Own Visa or MasterCard at Motley Fool
02:30PM  Visa Introduces Visa Checkout to Simplify Online Shopping on Any Device Business Wire
11:24AM  Visa Easily Wins This Head-To-Head Battle at Seeking Alpha
09:26AM  Can You Look Beyond eBay's Near-Term Challenges? at Seeking Alpha
14-Jul-14 03:05PM  Stocks rise, lifting Dow to record, after Citi beat at CNBC
01:03PM  3 Services Stocks Nudging The Sector Higher at TheStreet
01:00PM  Dow Today: Visa (V) Higher at TheStreet
12:59PM  Stocks rise, lifting Dow to record, after Citi beat at CNBC
05:25AM  Recent Buy: Visa at Seeking Alpha
13-Jul-14 06:48AM  VIP credit cards flaunt steel; plastic is fine at USA TODAY
04:37AM  Visa Is Only Expensive If You Can't Think 5 Years Ahead at Seeking Alpha
11-Jul-14 05:20PM  Total System Well Poised on Long-Term Growth Strategy Zacks
Visa Inc., a payments technology company, operates as a retail electronic payments network worldwide. The company facilitates commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities. It owns and operates VisaNet that is involved in the authorization, clearing, and settlement of payment transactions; and provision of fraud protection for account holders and assured payment for merchants. The company also offers a range of issuer processing services for participating issuers of Visa debit, prepaid, and ATM payment products. In addition, it provides electronic payment, risk management, and payment security solutions to online merchants; digital goods transactions services in online games, digital media, and social networks; and mobile financial services for mobile network operators and financial institutions in developing economies. The company offers its services under the Visa, Visa Electron, Interlink, and PLUS brands. Visa Inc. is based in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LUCIO ANTONIOEVP & CHIEF BRAND OFFICERJun 16Option Exercise0.003,582066,334Jun 17 06:39 PM
LUCIO ANTONIOEVP & CHIEF BRAND OFFICERJun 16Sale210.887,3041,540,26859,030Jun 17 06:39 PM
POLLITT BYRON H JRCHIEF FINANCIAL OFFICERMay 08Option Exercise0.0079,518097,351May 12 05:55 PM
POLLITT BYRON H JRCHIEF FINANCIAL OFFICERMay 08Sale210.0079,51816,698,78017,833May 12 05:55 PM
KELLY ALFRED F JRDirectorMar 17Buy222.701,575350,7531,575Mar 18 06:21 PM
Buse ElizabethEVP GLOBAL SOLUTIONSFeb 18Sale225.896,1591,391,25729,266Feb 19 06:04 PM
RICHEY ELLENEVP & CHIEF LEGAL OFFICERFeb 14Option Exercise0.008,677015,587Feb 19 05:56 PM
Buse ElizabethEVP GLOBAL SOLUTIONSFeb 14Option Exercise0.0013,016035,425Feb 19 06:04 PM
RICHEY ELLENEVP & CHIEF LEGAL OFFICERFeb 14Sale225.176,9481,564,48110,211Feb 19 05:56 PM
LUCIO ANTONIOEVP & CHIEF BRAND OFFICERJan 02Option Exercise0.007,163053,628Jan 03 08:35 PM
LUCIO ANTONIOEVP & CHIEF BRAND OFFICERJan 02Sale221.507,1631,586,60546,465Jan 03 08:35 PM
Fernandez-Carbajal Francisco JDirectorDec 11Sale202.2730,6006,189,4623,056Dec 13 05:09 PM
Fernandez-Carbajal Francisco JDirectorDec 10Sale199.9010,0001,999,00033,656Dec 13 05:09 PM
Buse ElizabethGLB EXEC SOLUTIONSDec 02Sale205.924,405907,07822,409Dec 03 07:36 PM
Sheedy William M.GLB EXEC CORP STR, M&A & GRNov 30Option Exercise0.008,5050101,749Dec 03 07:42 PM
RICHEY ELLENCHIEF ENTERPRISE RISK OFFICERNov 30Option Exercise0.008,505019,345Dec 03 07:41 PM
POLLITT BYRON H JRCHIEF FINANCIAL OFFICERNov 30Option Exercise0.0017,009046,746Dec 03 07:40 PM
LUCIO ANTONIOGLB CHIEF BRAND OFFICERNov 30Option Exercise0.006,379049,794Dec 03 07:39 PM
Floum Joshua R.GENERAL COUNSELNov 30Option Exercise0.008,505042,541Dec 03 07:37 PM
Buse ElizabethGLB EXEC SOLUTIONSNov 30Option Exercise0.008,505026,814Dec 03 07:36 PM
Buse ElizabethGLB EXEC SOLUTIONSNov 20Sale199.377,6481,524,78218,309Nov 21 06:11 PM
Buse ElizabethGLB EXEC SOLUTIONSNov 19Option Exercise0.0014,674023,954Nov 21 06:11 PM
Pang David J.DirectorNov 19Option Exercise0.001,202013,796Nov 21 06:04 PM
Fernandez-Carbajal Francisco JDirectorNov 19Option Exercise0.001,202043,656Nov 21 05:59 PM
RICHEY ELLENCHIEF ENTERPRISE RISK OFFICERNov 19Option Exercise0.0010,494025,488Nov 21 06:21 PM
POLLITT BYRON H JRCHIEF FINANCIAL OFFICERNov 19Option Exercise0.002,173035,786Nov 21 06:19 PM
RICHEY ELLENCHIEF ENTERPRISE RISK OFFICERNov 19Sale198.0811,7662,330,60913,722Nov 21 06:21 PM
Buse ElizabethGLB EXEC SOLUTIONSNov 08Sale197.551,353267,2859,280Nov 12 07:47 PM
Buse ElizabethGLB EXEC SOLUTIONSNov 05Option Exercise0.002,587010,633Nov 07 06:36 PM
RICHEY ELLENCHIEF ENTERPRISE RISK OFFICERNov 05Option Exercise0.001,124016,319Nov 06 08:00 PM
POLLITT BYRON H JRCHIEF FINANCIAL OFFICERNov 05Option Exercise0.002,249036,261Nov 06 06:48 PM
POLLITT BYRON H JRCHIEF FINANCIAL OFFICERNov 04Option Exercise0.0063,748097,760Nov 06 06:48 PM
POLLITT BYRON H JRCHIEF FINANCIAL OFFICERNov 04Sale197.4763,74812,588,31834,012Nov 06 06:48 PM
Sheedy William M.GBL EXEC CORP STR, M&A and GROct 18Sale197.818,5001,681,38599,759Oct 21 06:44 PM
LUCIO ANTONIOGBL CHIEF BRAND OFFICEROct 01Option Exercise0.009,537055,282Oct 02 05:04 PM
LUCIO ANTONIOGBL CHIEF BRAND OFFICEROct 01Sale190.879,5371,820,32745,745Oct 02 05:04 PM
Buse ElizabethHEAD OF GLOBAL SOLUTIONSAug 26Sale177.0317,5623,109,0018,046Aug 27 08:03 PM
Floum Joshua R.GENERAL COUNSELAug 06Sale183.9523,1334,255,31537,541Aug 06 07:23 PM
PPG [NYSE]
PPG Industries Inc.
IndexS&P 500 P/E28.42 EPS (ttm)7.39 Insider Own0.40% Shs Outstand138.26M Perf Week1.12%
Market Cap29.04B Forward P/E18.91 EPS next Y11.10 Insider Trans11.27% Shs Float137.75M Perf Month3.44%
Income1.06B PEG2.72 EPS next Q2.70 Inst Own76.80% Short Float0.80% Perf Quarter8.34%
Sales15.41B P/S1.88 EPS this Y55.00% Inst Trans0.00% Short Ratio1.95 Perf Half Y13.13%
Book/sh43.08 P/B4.88 EPS next Y17.69% ROA12.70% Target Price228.33 Perf Year35.56%
Cash/sh21.98 P/C9.55 EPS next 5Y10.47% ROE39.30% 52W Range153.73 - 213.01 Perf YTD11.48%
Dividend2.68 P/FCF25.43 EPS past 5Y17.00% ROI16.40% 52W High-1.40% Beta1.21
Dividend %1.28% Quick Ratio1.50 Sales past 5Y-1.00% Gross Margin43.00% 52W Low36.62% ATR2.54
Employees41400 Current Ratio1.90 Sales Q/Q17.00% Oper. Margin10.80% RSI (14)61.74 Volatility0.97% 1.18%
OptionableYes Debt/Eq0.57 EPS Q/Q57.30% Profit Margin13.50% Rel Volume0.81 Prev Close210.31
ShortableYes LT Debt/Eq0.56 EarningsJul 17 BMO Payout16.40% Avg Volume567.20K Price210.02
Recom1.80 SMA201.15% SMA503.08% SMA20010.21% Volume457,172 Change-0.14%
01-Jul-14Reiterated Deutsche Bank Buy $220 → $235
25-Apr-14Reiterated Argus Buy $216 → $224
21-Apr-14Reiterated Deutsche Bank Buy $213 → $220
06-Dec-13Reiterated Deutsche Bank Buy $195 → $210
22-Jul-13Reiterated UBS Neutral $148 → $156
22-Jul-13Reiterated RBC Capital Mkts Outperform $160 → $176
22-Jul-13Reiterated Barclays Equal Weight $157 → $167
12-Feb-13Resumed Barclays Equal Weight $149
23-Jan-13Reiterated Argus Buy $136 → $157
04-Jan-13Reiterated UBS Neutral $118 → $136
18-Dec-12Reiterated Deutsche Bank Buy $132 → $150
08-Aug-12Reiterated UBS Neutral $98 → $111
22-Jun-12Initiated Robert W. Baird Outperform $120
20-Apr-12Reiterated UBS Neutral $90 → $98
10-Apr-12Reiterated Barclays Equal Weight $101 → $105
01-Feb-12Reiterated Barclays Capital Equal Weight $92 → $101
18-Nov-11Reiterated Barclays Capital Equal Weight $85 → $93
30-Sep-11Resumed KeyBanc Capital Mkts Hold
23-Sep-11Initiated UBS Neutral $72
31-Aug-11Initiated Barclays Capital Equal Weight $85
21-Jul-14 05:15PM  PPG Industries Inks Deal to Sell Mt. Zion Facility to Fuyao Zacks
04:24PM  [$$] A Tough Paint Job for U.S. Manufacturers at The Wall Street Journal
03:30PM  [$$] A Tough Paint Job for U.S. Manufacturers at The Wall Street Journal
02:52PM  Wall Street Transcript Interview with James J. Owens, the President and CEO of H.B. Fuller Company (FUL) Wall Street Transcript
11:19AM  Cramer: Four Stocks to Lift Your Spirits at TheStreet
18-Jul-14 03:47PM  Paint: Underneath All The Boredom Are Great Investment Opportunities at Seeking Alpha
09:39AM  Company News for July 18, 2014 Zacks
09:01AM  PPG Reaches Agreement to Sell Mt. Zion Float Glass Manufacturing Facility Business Wire
17-Jul-14 08:07PM  Jim Cramer's 'Mad Money' Recap: Put on the Brakes at TheStreet
02:00PM  PPG Industries Earnings Call scheduled for 2:00 pm ET today CCBN
01:04PM  PPG Misses Q2 Sales Views As Sherwin-Williams Tops at Investor's Business Daily
01:00PM  PPG Industries (PPG) Q2 Earnings Trump on Gains in Europe Zacks
12:55PM  PPG INDUSTRIES INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Sta EDGAR Online
12:17PM  PPG INDUSTRIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
12:14PM  PPG Industries Earnings Call scheduled for 2:00 pm ET today CCBN
11:40AM  PPG Appoints McGarry Chief Operating Officer Business Wire
11:00AM  PPG INDUSTRIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
10:49AM  PPG Industries (PPG) Declares 67c Quarterly Dividend at TheStreet
10:34AM  [video] PPG Industries Profit Rises On Global Growth Led By Europe at TheStreet
10:11AM  PPG Directors Announce Quarterly Dividend of 67 Cents Per Share Business Wire
09:16AM  PPG Industries Earnings Call scheduled for 2:00 pm ET today CCBN
08:15AM  PPG Industries Earnings Call scheduled for 2:00 pm ET today CCBN
08:11AM  PPG Reports Record Second Quarter Net Sales and Earnings Business Wire
07:07AM  Q2 2014 PPG Industries Earnings Release - Before Market Open CCBN
16-Jul-14 07:20AM  Should You Buy PPG Industries (PPG) Ahead of Earnings? Zacks
15-Jul-14 10:30AM  Will PPG Industries (PPG) Keep the Earnings Streak Alive? Zacks
14-Jul-14 01:54PM  PPG Industries Is a Buy Ahead of Second-Quarter Earnings at TheStreet
13-Jul-14 06:21PM  Cramer's plan: 10 earnings plays for this week at CNBC
11-Jul-14 06:08PM  Cramer's plan: 10 earnings plays for next week at CNBC
06:08PM  Cramer's Game Plan: 10 earnings plays for next week at CNBC
10-Jul-14 10:38AM  Why Lower-Yielding Stocks Provide Better Long-Term Returns at Seeking Alpha
09-Jul-14 05:20PM  PPG Industries Boosts OMNI Plus Range with New Clearcoat Product Zacks
07-Jul-14 03:06PM  PPG Paints Over Sherwin-Williams Failure at Motley Fool
03-Jul-14 02:29PM  PPG INDUSTRIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
12:10PM  PPG Industries Closes Homax Group Acquisition Zacks
02-Jul-14 04:35PM  PPG Industries Closes Acquisition of Masterwork Zacks
12:40PM  Praxair Hikes Gas prices to Cover Increased Costs Zacks
10:20AM  PPG Industries, Inc. -- Moody's says PPG's Comex acquisition adds diversity but will not immediately impact its ratings Moody's
10:20AM  PPG Industries, Inc. -- Moody's says PPG's Comex acquisition adds diversity but will not immediately impact its ratings at Moody's
10:03AM  [video] Door Open for Japan to Reinterpret Constitution at MarketWatch
08:11AM  PPG Completes Acquisition of Specialty Coatings Supplier the Homax Group from Olympus Partners Business Wire
08:09AM  2 Ways To Play Innovation In Titanium Pigment Industry at Seeking Alpha
01-Jul-14 02:43PM  [$$] PPG Industries Steps Up to Buy Mexican Paint Maker Comex at The Wall Street Journal
02:20PM  PPG Industries Flies High on $2.3 Billion Comex Acquisition Zacks
10:53AM  [$$] PPG Industries Steps Up to Buy Mexican Paint Maker Comex at The Wall Street Journal
09:34AM  Company News for July 01, 2014 Zacks
09:25AM  Stock Downgrades: Xerox's Burns Gets the Third Degree at Minyanville
08:11AM  PPG Completes Acquisition of Pittsburgh-Based Architectural Paint Distributor, Masterwork Paint Company Business Wire
05:44AM  PPG Industries - Acquires Comex, Yet Limited Appeal After Huge Momentum at Seeking Alpha
12:16AM  [$$] PPG Industries Steps Up to Buy Mexican Paint Maker Comex at The Wall Street Journal
30-Jun-14 10:55PM  [$$] PPG Industries Steps Up to Buy Mexican Paint Maker Comex at The Wall Street Journal
08:24PM  [$$] PPG Industries Steps Up to Buy Mexican Paint Maker Comex at The Wall Street Journal
06:00PM  [video] Q2 a microcosm of 2014: Cramer at CNBC
04:10PM  Stocks End Mixed, Post Gains for Quarter Morningstar
02:54PM  U.S. chemicals maker PPG to buy Mexico's Comex for $2.3 bln Reuters
02:49PM  [$$] PPG to Acquire Mexico's Comex at The Wall Street Journal
01:58PM  MannKind Jumps On FDA Approval; Rayonier Shares Slide Benzinga
01:38PM  PPG to buy Mexico's Comex for $2.3bn at Financial Times
12:48PM  Why PPG Industries (PPG) Stock Is Gaining Today at TheStreet
12:31PM  PPG Industries buying Mexico's Comex for $2.3B AP
12:30PM  PPG Industries buying Mexico's Comex for $2.3B AP
12:20PM  Stocks end the quarter with mixed results Hot Stock Minute
12:13PM  Midday movers: Allergan, MBIA, Treehouse Foods & More at CNBC
12:01PM  MannKind, GoPro rise; Yahoo gains on upgrade at MarketWatch
10:46AM  PPG INDUSTRIES INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits EDGAR Online
10:29AM  Markets Edge Higher; PPG To Acquire Comex For $2.3 Billion Benzinga
10:28AM  PPG rises after acquiring former Sherwin-Williams target at theflyonthewall.com
10:12AM  [video] U.S. Markets Open Higher; Mannkind, PPG Industries In Focus at TheStreet
09:56AM  PPG rolls up Comex for $2.3B at TheStreet
09:48AM  [video] The Top Ten Stocks for Monday, June 30 at Bloomberg
09:46AM  PPG Industries (PPG) Reaches New Lifetime High Today at TheStreet
09:27AM  Why PPG Industries (PPG) Stock Is Gaining In Pre-Market Trading Today at TheStreet
09:16AM  PPG to Buy Mexican Paint Maker Consorcio Comex for $2.3 Billion at New York Times
09:16AM  PPG Industries to Buy Mexican Paint Company Consorcio Comex for $2.3 Billion at New York Times
09:14AM  PPG Industries To Acquire Comex For $2.3 Billion Benzinga
08:58AM  [$$] PPG to Acquire Mexico's Comex at The Wall Street Journal
08:53AM  Chemicals maker PPG Industries to buy Mexico's Comex for $2.3 bln Reuters
08:50AM  Morning Movers: Walter Energy Falls on S&P Cut; MannKind Gains at Barrons.com
08:46AM  PPG Industries buying Mexico's Comex for $2.3B AP
08:45AM  PPG Industries buying Mexico's Comex for $2.3B AP
08:44AM  PPG to acquire Mexicos Consorcio Comex for $2.3 billion at MarketWatch
08:40AM  [$$] PPG to Acquire Mexico's Comex at The Wall Street Journal
08:12AM  PPG to Step in Where Sherwin Failed With $2.3 Billion Comex Deal at Bloomberg
08:10AM  Coatings maker PPG Industries to buy Mexico's Comex for $2.3 bln Reuters
08:00AM  PPG Reaches Agreement to Acquire Comex Business Wire
27-Jun-14 09:34AM  PPG to Announce Second Quarter 2014 Results July 17 Business Wire
09:34AM  PPG to Announce Second Quarter 2014 Results July 17
26-Jun-14 06:00PM  Investor conundrum: Play cyclical or secular? at CNBC
06:00PM  Investor conundrum: Play cyclical or secular?
25-Jun-14 06:03PM  Jim Cramer: The best bets for the second half
06:03PM  Cramer's best bets for the second half at CNBC
06:03PM  Cramer: Best bets for second half
23-Jun-14 04:35PM  PPG Again Named by IDGs Computerworld among 2014 Best Places to Work in IT Business Wire
04:35PM  PPG Again Named by IDGs Computerworld among 2014 Best Places to Work in IT
21-Jun-14 06:00AM  Jim Cramer's Top Stock Picks: MON GIS PPG EOG UNP GWPH STZ at TheStreet
06:00AM  Jim Cramer's Top Stock Picks: MON GIS PPG EOG UNP GWPH STZ
18-Jun-14 12:50PM  PPG Industries Spends $40M on Brazil Plant Expansion Zacks
12:50PM  PPG Industries Spends $40M on Brazil Plant Expansion
11:39AM  Greed Is Good: Top Bull Market Dividend Aristocrats at Seeking Alpha
11:39AM  Greed Is Good: Top Bull Market Dividend Aristocrats
PPG Industries, Inc. manufactures and distributes coatings, optical and specialty materials, and glass products. The company operates in five segments: Performance Coatings, Industrial Coatings, Architectural Coatings, Optical and Specialty Materials, and Glass. It offers coatings products for automotive and commercial transport/fleet repair and refurbishing, light industrial coatings, and specialty coatings for signs; sealants, coatings, maintenance cleaners, and transparencies for commercial, military, regional jet, and general aviation aircraft and transparent armor for specialty applications; and coatings and finishes for the protection of metals and structures to metal fabricators, heavy duty maintenance contractors, and manufacturers of ships, bridges, and rail cars. The company also provides industrial and automotive coatings for manufacturing companies; adhesives and sealants for the automotive industry; metal pretreatments and related chemicals for industrial and automotive applications; and packaging coatings to aerosol, food, and beverage container manufacturers. In addition, it offers architectural coatings used by painting and maintenance contractors and by consumers to decorate and maintain residential and commercial building structures, as well as purchased sundries to painting contractors and consumers. Further, the company provides optical products, such as lenses, optical lens materials, and sun lenses; silicas comprising amorphous precipitated silicas for tire, battery separator, and other end-use markets; and substrates used for radio frequency identification tags and labels, e-passports, drivers' licenses, and identification cards applications. Additionally, it offers flat glass and continuous-strand fiber glass products for commercial and residential construction markets, and the wind energy, energy infrastructure, transportation, and electronics industries. The company was founded in 1883 and is headquartered in Pittsburgh, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BUNCH CHARLES EChairman and CEOJul 22Option Exercise88.7047,7004,230,990421,878Jul 23 01:24 PM
BUNCH CHARLES EChairman and CEOJul 22Sale210.1147,70010,022,272374,178Jul 23 01:24 PM
BUNCH CHARLES EChairman and CEOJul 21Option Exercise88.7047,7004,230,990421,878Jul 23 01:24 PM
BUNCH CHARLES EChairman and CEOJul 21Sale208.8147,7009,960,191374,178Jul 23 01:24 PM
NIEKAMP CYNTHIA ASr. VP, Automotive CoatingsApr 24Option Exercise88.708,700771,69037,981Apr 28 08:56 AM
NIEKAMP CYNTHIA ASr. VP, Automotive CoatingsApr 24Sale195.358,7001,699,58429,281Apr 28 08:56 AM
MCGARRY MICHAEL HExecutive Vice PresidentApr 23Option Exercise88.705,000443,50038,360Apr 24 09:14 AM
MCGARRY MICHAEL HExecutive Vice PresidentApr 23Sale197.385,000986,92133,360Apr 24 09:14 AM
SEKMAKAS VIKTORAS RExecutive Vice PresidentApr 22Option Exercise88.709,700860,39028,810Apr 23 09:14 AM
SEKMAKAS VIKTORAS RExecutive Vice PresidentApr 22Sale196.9114,7002,894,61714,110Apr 23 09:14 AM
BOST GLENN E IISr. VP & Gen. CounselFeb 26Option Exercise88.706,800603,16025,357Feb 27 12:07 PM
BOST GLENN E IISr. VP & Gen. CounselFeb 26Sale193.258,8891,717,79216,468Feb 27 12:07 PM
BUNCH CHARLES EChairman and CEOFeb 18Option Exercise61.8170,0004,326,700406,893Feb 19 04:05 PM
BUNCH CHARLES EChairman and CEOFeb 18Sale186.6970,00013,068,162336,893Feb 19 04:05 PM
RICHENHAGEN MARTINDirectorFeb 16Option Exercise0.001,12806,958Feb 19 11:11 AM
HOOPER MICHELE JDirectorFeb 16Option Exercise0.001,12804,346Feb 19 11:06 AM
BERGES JAMES GDirectorFeb 16Option Exercise0.001,12803,739Feb 19 10:50 AM
BUNCH CHARLES EChairman and CEOFeb 14Option Exercise61.8170,0004,326,700406,893Feb 19 04:05 PM
BUNCH CHARLES EChairman and CEOFeb 14Sale183.2170,00012,824,471336,893Feb 19 04:05 PM
NAVIKAS DAVID BSr. VP Strat Plan & Corp DevFeb 14Sale188.052,500470,12615,800Feb 19 04:02 PM
ELIAS RICHARD CSr. VP, Optical & SpecMatlsJan 27Sale181.644,538824,3049,141Jan 28 09:31 AM
MCGARRY MICHAEL HExecutive Vice PresidentJan 21Option Exercise61.815,000309,05034,513Jan 23 11:38 AM
MCGARRY MICHAEL HExecutive Vice PresidentJan 21Sale189.825,000949,10029,513Jan 23 11:38 AM
BUNCH CHARLES EChairman and CEOOct 22Option Exercise34.0955,0001,874,950391,893Oct 23 01:33 PM
BERGES JAMES GDirectorOct 22Option Exercise71.882,500179,7009,934Oct 23 01:42 PM
BERGES JAMES GDirectorOct 22Sale178.252,500445,6257,434Oct 23 01:42 PM
NAVIKAS DAVID BSr. VP Strat Plan & Corp DevOct 22Sale177.832,840505,03618,831Oct 23 01:37 PM
BUNCH CHARLES EChairman and CEOOct 22Sale178.6055,0009,822,984336,893Oct 23 01:33 PM
BUNCH CHARLES EChairman and CEOOct 21Option Exercise34.0985,0002,897,650421,893Oct 23 01:33 PM
BUNCH CHARLES EChairman and CEOOct 21Sale176.1985,00014,975,860336,893Oct 23 01:33 PM
HAYNES VICTORIA FDirectorAug 26Option Exercise71.881,25089,8501,574Aug 27 09:51 AM
HAYNES VICTORIA FDirectorAug 26Sale161.581,250201,972324Aug 27 09:51 AM
MCGARRY MICHAEL HExecutive Vice PresidentAug 07Option Exercise62.3113,600847,38443,113Aug 09 07:51 AM
SEKMAKAS VIKTORAS RExecutive Vice PresidentAug 07Option Exercise66.6015,3001,018,97337,989Aug 09 07:54 AM
SEKMAKAS VIKTORAS RExecutive Vice PresidentAug 07Sale161.1823,4453,778,85914,544Aug 09 07:54 AM
MCGARRY MICHAEL HExecutive Vice PresidentAug 07Sale161.5813,6002,197,44329,513Aug 09 07:51 AM
BUNCH CHARLES EChairman and CEOAug 01Option Exercise63.6945,0002,866,050381,893Aug 02 12:10 PM
HAYNES VICTORIA FDirectorAug 01Option Exercise71.881,25089,8501,574Aug 02 12:17 PM
HAYNES VICTORIA FDirectorAug 01Sale162.241,250202,800324Aug 02 12:17 PM
BUNCH CHARLES EChairman and CEOAug 01Sale162.4745,0007,311,350336,893Aug 02 12:10 PM
BUNCH CHARLES EChairman and CEOJul 31Option Exercise63.6950,0003,184,500386,893Aug 02 12:10 PM
ELIAS RICHARD CSr. VP, Optical & SpecMatlsJul 31Option Exercise61.8115,000927,15028,679Aug 02 12:14 PM
ELIAS RICHARD CSr. VP, Optical & SpecMatlsJul 31Sale160.6615,0002,409,95613,679Aug 02 12:14 PM
BUNCH CHARLES EChairman and CEOJul 31Sale160.9250,0008,045,783336,893Aug 02 12:10 PM